Natural Alternatives: Feingold Diet and Fresh Lemon Balm for ADHD

Information about the Fiengold Diet, a dietary intervention and Fresh Lemon Balm for treating ADHD symptoms. Also an article on little scientific evidence regarding the relationship between food allergies and behavior or learning problems.

The Fiengold Diet

Moira from South Africa wrote to us saying.

"Hello Simon,
I must tell you some information which a friend passed on to me. She has a son, who is now 21 years old, doing his Masters Degree in Engineering. When he was 15 months old, her doctor diagnosed him as having ADHD. He put him on Ritalin, but she was not happy and spent considerable time and effort to try an alternative method. She eventually got hold of a book, written by Ben F. Feingold, MD, called "Why your child is hyperactive". He apparently runs (or did at the time) a clinic at Kaiser-Permanente Medical Centre in San Francisco. He stated that most learning difficulties are caused by artificial food flavours and colours. She experimented with all sorts of foods and discovered over time exactly what caused his mood swings. From being an impossible and ,what teachers called, a backward child, he overcame his problems and is now a brilliant student."

For further details including more testimonials, go to the Feingold Association's web site at http://www.feingold.org/. (Please be aware that some of the information on the Feingold website is for members only i.e. you have to pay a subscription to read it.)

Carol wrote to us saying......

"Dear Simon,
I just found this site and wanted to say that my 4 year old son has ADHD and has been taking eye-q for three months and I know its helping him. But I also follow the Feingold diet and live a life as close to the Rudolph Steiner philosophy as possible. I took Michael to a noisy busy New Year's Party last night. Imagine the scene - a lot of tipsy adults and a dozen or more kids running about. Michael screamed and bit a little boy and we left. I apologised to him later for putting him into a situation he couldn't deal with and he is happily playing with his sister today and is once again the quiet happy little boy I adore. If only he could deal with the other world of noise and "normality" just occasionally, but he cant.

Sam Goldstein, Ph.D. & Barbara Ingersoll, Ph.D. mention the Feingold Diet in their article "CONTROVERSIAL TREATMENTS FOR CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER" as follows:

Dietary Intervention

"Among the best known dietary interventions, the Feingold Diet has advocated that children sensitive to a variety of foods and food colorings, including preservatives, may develop symptoms of ADHD as a toxic reaction to these substances. Over the years advocates of these dietary interventions have made dramatic claims. They have stated that additive-free diets will improve most if not all children's learning and attention problems. They describe case studies in which children could be removed from drug therapy if their diet was maintained. They also report improvements in school for these children and subsequent deterioration in learning and behavior when the diet is not followed.

Although dietary interventions are popular, few studies have reported success and for most of these, statistical problems abound. The lack of well-controlled studies is also true for those who propose a relationship between allergies and behavior or learning problems. Although proponents of these dietary approaches may acknowledge that careful scientific studies are necessary, such studies have not yet been conducted.

A large number of studies, however, have examined the relationship between sugar and ADHD. However, most of them are difficult to interpret. A few well-designed studies have found some effects of sugar on behavior but these effects are very small and only a small percentage of children with ADHD appear vulnerable.

After careful analysis of the existing evidence, numerous researchers have concluded that there is limited, if any, support for a link between diet and children's learning and behavior. Of course, like all children, we know that children with ADHD require a healthy, well-balanced diet. At this time, however, it has not been shown that dietary interventions offer significant help for children with learning and attention problems."

FOCUS

Bonnie wrote to us saying......
"I thought I would write a note and tell you that my 14 yr old son Jordan is having tremendous success with Focus for Children by Natures Way. We have homeschooled using Stevenson Language Skills (Menomics), Vision Therapy, NACD, Sanomas Auditory Therapy, and even a little bit of Norfolk. He has spent years with private tutors and one-on-one instruction which I am sure gave him the skills he needed and has helped tremndously. But recently he has begun taking Focus and we are seeing him begin to soar. He is reading and writing and behaving appropriately...things he could never accomplish before. Yes, he is still working hard and his program at school is adaptive...but he is doing it...and a year ago I never would have dreamed he could.

Fresh Lemon Balm - Melissa officinals

The following is excerpted from the Health Search newspaper published by Wilson Publications, Owensboro, KY 42303

Melissa is an aromatic herb with a distinctly spicy, lemony taste. In traditional medicine, it was considered a cure-all for a number of conditions including nervous problems, insomnia, female discomforts, headache, toothache, sores, cramps, tumors, and insect bites. Melissa's various actions include carminative, diaphoretic, anti-spasmodic, stomachic and emmenagogue.

In Europe, where the study of natural medicines is much more advanced than in the U.S., there is a German Kommission E Monograph regarding Melissa, attesting to its clinical uses in nervous disturbance of sleep, functional gastrointestinal disorders, and as an appetite stimulant for those needing it. Further studies with Melissa have revealed strong antiviral properties, especially with regard to herpes virus in a topical application. Long celebrated for its benefits with hyperactivity in children, Melissa, when combined with other similar sedative herbs according to the German Kommission E may be advantageous.

Ed. Note: Please remember, we do not endorse any treatments and strongly advise you to check with your doctor before using, stopping or changing any treatment


 


 

APA Reference
Staff, H. (2009, January 2). Natural Alternatives: Feingold Diet and Fresh Lemon Balm for ADHD, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/adhd/articles/feingold-diet-and-fresh-lemon-balm-for-adhd

Last Updated: May 6, 2019

Intimacy Not Just Sex

It's better than sex and it's more than just love. It's a feeling, a closeness.

Intimacy.

A legion of columnists, advice givers, therapists and pastors say society is starved for intimacy. In the been-there, done-that '90s, people are sexually saturated, yet strangely disconnected.

Intimacy even has a smell: Jasmine, Bulgarian rose, sandalwood and ylang ylang, as marketed by First Herb Shop. But its essence is strangely absent from day-to-day life.

In an interview with USA Today Weekend, Dr. Drew Pinsky, co-host of MTV's "Loveline" sex-advice program, says young adults are unable to establish intimacy because they're too into sexual thrills.

His advice: "Get away from the sex part and into intimacy. Commit yourself to a relationship and don't look for ways to get out."

"Intimacy is the way people find happiness. Monogamy is required for intimacy to flourish," he says.

Marked by close association, acquaintance and familiarity, intimacy also pertains to one's deepest nature. People assume this means one's sexuality, but a hunger for intimacy cannot be satisfied through unlimited sex, says Rabbi Shmuley Boteach, author of the recent book "Kosher Sex." He bluntly informs readers that sex often works against intimacy. To really know your spouse, abstain for two weeks a month, he says.
"I am trying to identify what [the public] really, really wants," he said. "The overwhelming desire for sex is a manifestation of an inner desire for intimacy."

He continues: "Sex thrives specifically in a veiled arena, where fantasy and allure are allowed their place. Moreover, without modesty, there can be no intimacy. When sex is too public -- when it is broadcast to the world -- it is then no longer about two people sharing something special and exclusive.

"Modesty dictates that there is a curtain that separates my private space from the rest of the world. Intimacy dictates that there are times when that curtain is raised by us in order to invite in a special person for exclusive and intimate acts."

The lack in our culture of knowing and being known echoes back to Simon and Garfunkel-esque 1960s songs of silence and loneliness, when fame was 15 minutes long and people got shot in places like New York while bystanders stood mutely by.

Intimacy has its own cliche; namely, that men fear it but women relish it. However, fear of intimacy "runs almost like an epidemic through the lives of young women today," writes Boston psychotherapist Mira Kirschenbaum in her new book, "Women & Love."

"The keynote of fear of intimacy is that falling in love feels like bad news," she writes. "When your heart sends you that letter that you're falling in love, it feels like you've gotten a letter from the IRS telling you they're auditing you."

Too much intimacy can be painful. Joyce Kovelman, a psychotherapist quoted on the www.cupidnet.com Web site, says few people can be intimate and honest for more than a few moments at a time.

"The more invested in a relationship, the harder it is to be honest," she writes. "The risk seems greater. Each of us [is] so used to being told 'don't,' 'shouldn't,' 'mustn't' and 'can't,' and how we're supposed to be. It's no wonder that we hesitate to reveal our innermost ideas and needs."

The religious world has caught onto this felt need, with vocalists such as rock star Carmen Licciardello promising fans that his music ushers one into "an exciting and intimate experience with our Creator."

God is portrayed as the one safe place for intimacy in recent releases such as "Intimate Bride: Gentle Worship for Soaking in God's Presence" from the Toronto Airport Christian Fellowship. Late last year, Vineyard Music Group, a California-based company, released a CD titled "Intimacy."

"Intimacy is critical to relationship with God," says VMG General Manager Alex MacDougall. "We don't sing about God. We sing to God.

"I think we're all pretty disconnected," he said. "If a Christian has intimacy with God, it's a way of feeling connected. Most of the time, relationships with other people are devalued. People are selfish. They have no time.

"There's a difference between lovemaking and sex. There's a difference between a relationship with God and a belief system. People want to experience a deeper level of love for God. The response is a flooding of peace in your heart and in your mind. That is one of the key payoffs here," Mr. MacDougall said.

Intimacy should be sought even in the working world, says Brian R. Smith, author of "Beyond the Magic Circle: The Role of Intimacy in Business."

He writes, "Choose your own work and your own feelings about it. Create a reality where your work serves as a vital extension of your celebration of your most intimate acts, thoughts and emotions. . . . See yourself and what you do as the result of intimate meaningful choices right now.

"Then and only then will you experience the intimate, quality reality available far above and beyond that offered by even the most exalted magic circles currently in vogue in American business," he says.

next: Sex and Intimacy

APA Reference
Staff, H. (2009, January 2). Intimacy Not Just Sex, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/sex/psychology-of-sex/intimacy-not-just-sex

Last Updated: January 14, 2014

Have a Nice Flight!

Achieving Comfortable FlightTo the millions of travelers plagued with the crippling fear of flying, these words bring little or no comfort. Each year a growing number of business flyers inefficiently juggle schedules to include alternate means of travel. And the vacationer is limited in choosing destinations by the time restraints of ground transportation. Acknowledging the intensity of this phenomenon, Dr. Reid Wilson and Captain T. W. Cummings collaborated to produce a thorough approach to achieving this much sought comfort level for commercial air travel. The Achieving Comfortable Flight series is not a miracle cure but rather a realistic method, systematically designed to solve a growing problem. The team formed by Dr. Wilson and Captain Cummings matches a clinical knowledge of the fear with a practical understanding of the cause. From these combined efforts the ACF series is now available in booklet/tape format for use in the privacy of home or office. No longer does the busy executive have to wait for a seminar that fits his schedule. No embarrassment for that traveler who feels compelled to hide his fear. No longer do you have to suffer. The ACF series provides you with the luxury of learning in your own chosen environment.

The ACF series is presented in two booklets, four accompanying tapes, and a set of quick reference cards. Noting that there are differing levels of fearful flyers, the series is designed so that you select an area of concentration or pursue the entire study. The booklets present alternatives to assist you in conquering your fears, as well as a detail of the "nuts and bolts" of an airline craft in easy, non-technical language. The tapes range from breathing exercises and skills review to an in-depth guide through a flight. They are also designed for when you desire more practice or information. In addition, a set of quick reference cards is included for later review.

The combination of the booklets and tapes will help you develop the skills to overcome your own personal fears. Millions of Americans enjoy flying as a fast, safe and comfortable means of transportation. Let us help you be one of them.

About the Authors

Captain T.W. Cummings

hp-anxiety-art-189-healthyplacehas 36 years of flying experience, including WWII bomber missions and a distinguished 31 year Pan Am career. The Captain established the "Freedom from Fear of Flying" program in 1975, and has conducted over 200 seminars throughout the US and overseas. In addition, his expertise has been requested in books such as Handbook of Phobia Therapy (Jason Aronson, Inc.) and eventually his own Freedom from the Fear of Flying (Pocket Books).

R. Reid Wilson, Ph.D.

directs the Anxiety Disorders Treatment Program in Chapel Hill and Durham, North Carolina. He is also Clinical Associate Professor of Psychiatry at the University of North Carolina School of Medicine. Dr. Wilson specializes in the treatment of anxiety disorders. He designed and served as lead psychologist for American Airlines' first national program for the fearful flier. Dr. Wilson is on the Board of Directors of the Anxiety Disorders Association of America. He served as Program Chair of the National Conferences on Anxiety Disorders from 1988-1991.

next: Anxiety Medication Profiles
~ back to Anxieties Site homepage
~ anxiety-panic library articles
~ all anxiety disorders articles

APA Reference
Staff, H. (2009, January 2). Have a Nice Flight!, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/anxiety-panic/articles/have-a-nice-flight

Last Updated: June 30, 2016

Psychiatric Medications: Medications for Mental Illness

In-depth overview of psychiatric medications. Covers types of psychiatric medications, benefits and side-effects of psychiatric medications, taking psychiatric medications during pregnancy, and more.

Special Message

This booklet is designed to help mental health patients and their families understand how and why psychiatric medications can be used as part of the treatment of mental health problems.

It is important for you to be well informed about medications you may need. You should know what medications you take and the dosage, and learn everything you can about them. Many medications now come with patient package inserts, describing the medication, how it should be taken, and side effects to look for. When you go to a new doctor, always take with you a list of all of the prescribed medications (including dosage), over-the-counter medications, and vitamin, mineral, and herbal supplements you take. The list should include herbal teas and supplements such as St. John's wort, echinacea, ginkgo, ephedra, and ginseng. Almost any substance that can change behavior can cause harm if used in the wrong amount or frequency of dosing, or in a bad combination. Drugs differ in the speed, duration of action, and in their margin for error.


continue story below


If you are taking more than one medication, and at different times of the day, it is essential that you take the correct dosage of each medication. An easy way to make sure you do this is to use a 7-day pillbox, available in any pharmacy, and to fill the box with the proper medication at the beginning of each week. Many pharmacies also have pillboxes with sections for medications that must be taken more than once a day.

This booklet is intended to inform you, but it is not a "do-it-yourself" manual. Leave it to the doctor, working closely with you, to diagnose mental illness, interpret signs and symptoms of the illness, prescribe and manage medication, and explain any side effects. This will help you ensure that you use medication most effectively and with minimum risk of side effects or complications.

Introduction

Anyone can develop a mental illness—you, a family member, a friend, or a neighbor. Some disorders are mild; others are serious and long-lasting. These conditions can be diagnosed and treated. Most people can live better lives after treatment. And psychotherapeutic medications are an increasingly important element in the successful treatment of mental illness.

Medications for mental illnesses were first introduced in the early 1950s with the antipsychotic chlorpromazine. Other medications have followed. These medications have changed the lives of people with these disorders for the better.

Psychotherapeutic medications also may make other kinds of treatment more effective. Someone who is too depressed to talk, for instance, may have difficulty communicating during psychotherapy or counseling, but the right medication may improve symptoms so the person can respond. For many patients, a combination of psychotherapy and medication can be an effective method of treatment.

Another benefit of these medications is an increased understanding of the causes of mental illness. Scientists have learned much more about the workings of the brain as a result of their investigations into how psychotherapeutic medications relieve the symptoms of disorders such as psychosis, depression, anxiety, obsessive-compulsive disorder, and panic disorder.

continue: Purpose of Psychiatric Medications and Questions for Your Doctor


Relief from Symptoms

Just as aspirin can reduce a fever without curing the infection that causes it, psychotherapeutic medications act by controlling symptoms. Psychotherapeutic medications do not cure mental illness, but in many cases, they can help a person function despite some continuing mental pain and difficulty coping with problems. For example, drugs like chlorpromazine can turn off the "voices" heard by some people with psychosis and help them to see reality more clearly. And antidepressants can lift the dark, heavy moods of depression. The degree of response—ranging from a little relief of symptoms to complete relief—depends on a variety of factors related to the individual and the disorder being treated.

How long someone must take a psychotherapeutic medication depends on the individual and the disorder. Many depressed and anxious people may need medication for a single period—perhaps for several months—and then never need it again. People with conditions such as schizophrenia or bipolar disorder (also known as manic-depressive illness), or those whose depression or anxiety is chronic or recurrent, may have to take medication indefinitely.

Like any medication, psychotherapeutic medications do not produce the same effect in everyone. Some people may respond better to one medication than another. Some may need larger dosages than others do. Some have side effects, and others do not. Age, sex, body size, body chemistry, physical illnesses and their treatments, diet, and habits such as smoking are some of the factors that can influence a medication's effect.

Questions for Your Doctor

You and your family can help your doctor find the right medications for you. The doctor needs to know your medical history, other medications being taken, and life plans such as hoping to have a baby. After taking the medication for a short time, you should tell the doctor about favorable results as well as side effects. The Food and Drug Administration (FDA) and professional organizations recommend that the patient or a family member ask the following questions when a medication is prescribed:


continue story below


  • What is the name of the medication, and what is it supposed to do?
  • How and when do I take it, and when do I stop taking it?
  • What foods, drinks, or other medications should I avoid while taking the prescribed medication?
  • Should it be taken with food or on an empty stomach?
  • Is it safe to drink alcohol while on this medication?
  • What are the side effects, and what should I do if they occur?
  • Is a Patient Package Insert for the medication available?

Medications for Mental Illness

This booklet describes medications by their generic (chemical) names and in italics by their trade names (brand names used by pharmaceutical companies). They are divided into four large categories—antipsychotic, antimanic, antidepressant, and antianxiety medications. Medications that specifically affect children, the elderly, and women during the reproductive years are discussed in a separate section of the booklet.

Lists at the end of the booklet give the generic name and the trade name of the most commonly prescribed medications and note the section of the booklet that contains information about each type. A separate chart shows the trade and generic names of medications commonly prescribed for children and adolescents.

Treatment evaluation studies have established the effectiveness of the medications described here, but much remains to be learned about them. The National Institute of Mental Health, other Federal agencies, and private research groups are sponsoring studies of these medications. Scientists are hoping to improve their understanding of how and why these medications work, how to control or eliminate unwanted side effects, and how to make the medications more effective.

continue: Antipsychotic Medications


Antipsychotic Medications

A person who is psychotic is out of touch with reality. People with psychosis may hear "voices" or have strange and illogical ideas (for example, thinking that others can hear their thoughts, or are trying to harm them, or that they are the President of the United States or some other famous person). They may get excited or angry for no apparent reason, or spend a lot of time by themselves, or in bed, sleeping during the day and staying awake at night. The person may neglect appearance, not bathing or changing clothes, and may be hard to talk to—barely talking or saying things that make no sense. They often are initially unaware that their condition is an illness.

These kinds of behaviors are symptoms of a psychotic illness such as schizophrenia. Antipsychotic medications act against these symptoms. These medications cannot "cure" the illness, but they can take away many of the symptoms or make them milder. In some cases, they can shorten the course of an episode of the illness as well.

There are a number of antipsychotic (neuroleptic) medications available. These medications affect neurotransmitters that allow communication between nerve cells. One such neurotransmitter, dopamine, is thought to be relevant to schizophrenia symptoms. All these medications have been shown to be effective for schizophrenia. The main differences are in the potency—that is, the dosage (amount) prescribed to produce therapeutic effects—and the side effects. Some people might think that the higher the dose of medication prescribed, the more serious the illness; but this is not always true.

The first antipsychotic medications were introduced in the 1950s. Antipsychotic medications have helped many patients with psychosis lead a more normal and fulfilling life by alleviating such symptoms as hallucinations, both visual and auditory, and paranoid thoughts. However, the early antipsychotic medications often have unpleasant side effects, such as muscle stiffness, tremor, and abnormal movements, leading researchers to continue their search for better drugs.


continue story below


The 1990s saw the development of several new drugs for schizophrenia, called "atypical antipsychotics." Because they have fewer side effects than the older drugs, today they are often used as a first-line treatment. The first atypical antipsychotic, clozapine (Clozaril), was introduced in the United States in 1990. In clinical trials, this medication was found to be more effective than conventional or "typical" antipsychotic medications in individuals with treatment-resistant schizophrenia (schizophrenia that has not responded to other drugs), and the risk of tardive dyskinesia (a movement disorder) was lower. However, because of the potential side effect of a serious blood disorder—agranulocytosis (loss of the white blood cells that fight infection)—patients who are on clozapine must have a blood test every 1 or 2 weeks. The inconvenience and cost of blood tests and the medication itself have made maintenance on clozapine difficult for many people. Clozapine, however, continues to be the drug of choice for treatment-resistant schizophrenia patients.

Several other atypical antipsychotics have been developed since clozapine was introduced. The first was risperidone (Risperdal), followed by olanzapine (Zyprexa), quetiapine (Seroquel), and ziprasidone (Geodon). Each has a unique side effect profile, but in general, these medications are better tolerated than the earlier drugs.

All these medications have their place in the treatment of schizophrenia, and doctors will choose among them. They will consider the person's symptoms, age, weight, and personal and family medication history.

Dosages and Side Effects

Some drugs are very potent and the doctor may prescribe a low dose. Other drugs are not as potent and a higher dose may be prescribed.

Unlike some prescription drugs, which must be taken several times during the day, some antipsychotic medications can be taken just once a day. In order to reduce daytime side effects such as sleepiness, some medications can be taken at bedtime. Some antipsychotic medications are available in "depot" forms that can be injected once or twice a month.

Most side effects of antipsychotic medications are mild. Many common ones lessen or disappear after the first few weeks of treatment. These include drowsiness, rapid heartbeat, and dizziness when changing position.

Some people gain weight while taking medications and need to pay extra attention to diet and exercise to control their weight. Other side effects may include a decrease in sexual ability or interest, problems with menstrual periods, sunburn, or skin rashes. If a side effect occurs, the doctor should be told. He or she may prescribe a different medication, change the dosage or schedule, or prescribe an additional medication to control the side effects.

Just as people vary in their responses to antipsychotic medications, they also vary in how quickly they improve. Some symptoms may diminish in days; others take weeks or months. Many people see substantial improvement by the sixth week of treatment. If there is no improvement, the doctor may try a different type of medication. The doctor cannot tell beforehand which medication will work for a person. Sometimes a person must try several medications before finding one that works.

If a person is feeling better or even completely well, the medication should not be stopped without talking to the doctor. It may be necessary to stay on the medication to continue feeling well. If, after consultation with the doctor, the decision is made to discontinue the medication, it is important to continue to see the doctor while tapering off medication. Many people with bipolar disorder, for instance, require antipsychotic medication only for a limited time during a manic episode until mood-stabilizing medication takes effect. On the other hand, some people may need to take antipsychotic medication for an extended period of time. These people usually have chronic (long-term, continuous) schizophrenic disorders, or have a history of repeated schizophrenic episodes, and are likely to become ill again. Also, in some cases a person who has experienced one or two severe episodes may need medication indefinitely. In these cases, medication may be continued in as low a dosage as possible to maintain control of symptoms. This approach, called maintenance treatment, prevents relapse in many people and removes or reduces symptoms for others.

Multiple Medications

Antipsychotic medications can produce unwanted effects when taken with other medications. Therefore, the doctor should be told about all medicines being taken, including over-the-counter medications and vitamin, mineral, and herbal supplements, and the extent of alcohol use. Some antipsychotic medications interfere with antihypertensive medications (taken for high blood pressure), anticonvulsants (taken for epilepsy), and medications used for Parkinson's disease. Other antipsychotics add to the effect of alcohol and other central nervous system depressants such as antihistamines, antidepressants, barbiturates, some sleeping and pain medications, and narcotics.

Other Effects

Long-term treatment of schizophrenia with one of the older, or "conventional," antipsychotics may cause a person to develop tardive dyskinesia (TD). Tardive dyskinesia is a condition characterized by involuntary movements, most often around the mouth. It may range from mild to severe. In some people, it cannot be reversed, while others recover partially or completely. Tardive dyskinesia is sometimes seen in people with schizophrenia who have never been treated with an antipsychotic medication; this is called "spontaneous dyskinesia."1 However, it is most often seen after long-term treatment with older antipsychotic medications. The risk has been reduced with the newer "atypical" medications. There is a higher incidence in women, and the risk rises with age. The possible risks of long-term treatment with an antipsychotic medication must be weighed against the benefits in each case. The risk for TD is 5 percent per year with older medications; it is less with the newer medications.

continue: Antimanic Medications


Antimanic Medications

Bipolar disorder is characterized by cycling mood changes: severe highs (mania) and lows (depression). Episodes may be predominantly manic or depressive, with normal mood between episodes. Mood swings may follow each other very closely, within days (rapid cycling), or may be separated by months to years. The "highs" and "lows" may vary in intensity and severity and can co-exist in "mixed" episodes.

When people are in a manic "high," they may be overactive, overly talkative, have a great deal of energy, and have much less need for sleep than normal. They may switch quickly from one topic to another, as if they cannot get their thoughts out fast enough. Their attention span is often short, and they can be easily distracted. Sometimes people who are "high" are irritable or angry and have false or inflated ideas about their position or importance in the world. They may be very elated, and full of grand schemes that might range from business deals to romantic sprees. Often, they show poor judgment in these ventures. Mania, untreated, may worsen to a psychotic state.

In a depressive cycle the person may have a "low" mood with difficulty concentrating; lack of energy, with slowed thinking and movements; changes in eating and sleeping patterns (usually increases of both in bipolar depression); feelings of hopelessness, helplessness, sadness, worthlessness, guilt; and, sometimes, thoughts of suicide.

Lithium

The medication used most often to treat bipolar disorder is lithium. Lithium evens out mood swings in both directions—from mania to depression, and depression to mania—so it is used not just for manic attacks or flare-ups of the illness but also as an ongoing maintenance treatment for bipolar disorder.

Although lithium will reduce severe manic symptoms in about 5 to 14 days, it may be weeks to several months before the condition is fully controlled. Antipsychotic medications are sometimes used in the first several days of treatment to control manic symptoms until the lithium begins to take effect. Antidepressants may also be added to lithium during the depressive phase of bipolar disorder. If given in the absence of lithium or another mood stabilizer, antidepressants may provoke a switch into mania in people with bipolar disorder.


continue story below


A person may have one episode of bipolar disorder and never have another, or be free of illness for several years. But for those who have more than one manic episode, doctors usually give serious consideration to maintenance (continuing) treatment with lithium.

Some people respond well to maintenance treatment and have no further episodes. Others may have moderate mood swings that lessen as treatment continues, or have less frequent or less severe episodes. Unfortunately, some people with bipolar disorder may not be helped at all by lithium. Response to treatment with lithium varies, and it cannot be determined beforehand who will or will not respond to treatment.

Regular blood tests are an important part of treatment with lithium. If too little is taken, lithium will not be effective. If too much is taken, a variety of side effects may occur. The range between an effective dose and a toxic one is small. Blood lithium levels are checked at the beginning of treatment to determine the best lithium dosage. Once a person is stable and on a maintenance dosage, the lithium level should be checked every few months. How much lithium people need to take may vary over time, depending on how ill they are, their body chemistry, and their physical condition.

Side Effects of Lithium

When people first take lithium, they may experience side effects such as drowsiness, weakness, nausea, fatigue, hand tremor, or increased thirst and urination. Some may disappear or decrease quickly, although hand tremor may persist. Weight gain may also occur. Dieting will help, but crash diets should be avoided because they may raise or lower the lithium level. Drinking low-calorie or no-calorie beverages, especially water, will help keep weight down. Kidney changes—increased urination and, in children, enuresis (bed wetting)—may develop during treatment. These changes are generally manageable and are reduced by lowering the dosage. Because lithium may cause the thyroid gland to become underactive (hypothyroidism) or sometimes enlarged (goiter), thyroid function monitoring is a part of the therapy. To restore normal thyroid function, thyroid hormone may be given along with lithium.

Because of possible complications, doctors either may not recommend lithium or may prescribe it with caution when a person has thyroid, kidney, or heart disorders, epilepsy, or brain damage. Women of childbearing age should be aware that lithium increases the risk of congenital malformations in babies. Special caution should be taken during the first 3 months of pregnancy.

Anything that lowers the level of sodium in the body—reduced intake of table salt, a switch to a low-salt diet, heavy sweating from an unusual amount of exercise or a very hot climate, fever, vomiting, or diarrhea—may cause a lithium buildup and lead to toxicity. It is important to be aware of conditions that lower sodium or cause dehydration and to tell the doctor if any of these conditions are present so the dose can be changed.

Lithium, when combined with certain other medications, can have unwanted effects. Some diuretics—substances that remove water from the body—increase the level of lithium and can cause toxicity. Other diuretics, like coffee and tea, can lower the level of lithium. Signs of lithium toxicity may include nausea, vomiting, drowsiness, mental dullness, slurred speech, blurred vision, confusion, dizziness, muscle twitching, irregular heartbeat, and, ultimately, seizures. A lithium overdose can be life-threatening. People who are taking lithium should tell every doctor who is treating them, including dentists, about all medications they are taking.

With regular monitoring, lithium is a safe and effective drug that enables many people, who otherwise would suffer from incapacitating mood swings, to lead normal lives.

continue: Anticonvulsant Medications


Anticonvulsants

Some people with symptoms of mania who do not benefit from or would prefer to avoid lithium have been found to respond to anticonvulsant medications commonly prescribed to treat seizures.

The anticonvulsant valproic acid (Depakote, divalproex sodium) is the main alternative therapy for bipolar disorder. It is as effective in non-rapid-cycling bipolar disorder as lithium and appears to be superior to lithium in rapid-cycling bipolar disorder.2 Although valproic acid can cause gastrointestinal side effects, the incidence is low. Other adverse effects occasionally reported are headache, double vision, dizziness, anxiety, or confusion. Because in some cases valproic acid has caused liver dysfunction, liver function tests should be performed before therapy and at frequent intervals thereafter, particularly during the first 6 months of therapy.

Studies conducted in Finland in patients with epilepsy have shown that valproic acid may increase testosterone levels in teenage girls and produce polycystic ovary syndrome (POS) in women who began taking the medication before age 20.3,4 POS can cause obesity, hirsutism (body hair), and amenorrhea. Therefore, young female patients should be monitored carefully by a doctor.

Other anticonvulsants used for bipolar disorder include carbamazepine (Tegretol), lamotrigine (Lamictal), gabapentin (Neurontin), and topiramate (Topamax). The evidence for anticonvulsant effectiveness is stronger for acute mania than for long-term maintenance of bipolar disorder. Some studies suggest particular efficacy of lamotrigine in bipolar depression. At present, the lack of formal FDA approval of anticonvulsants other than valproic acid for bipolar disorder may limit insurance coverage for these medications.


continue story below


Most people who have bipolar disorder take more than one medication. Along with the mood stabilizer—lithium and/or an anticonvulsant—they may take a medication for accompanying agitation, anxiety, insomnia, or depression. It is important to continue taking the mood stabilizer when taking an antidepressant because research has shown that treatment with an antidepressant alone increases the risk that the patient will switch to mania or hypomania, or develop rapid cycling.5 Sometimes, when a bipolar patient is not responsive to other medications, an atypical antipsychotic medication is prescribed. Finding the best possible medication, or combination of medications, is of utmost importance to the patient and requires close monitoring by a doctor and strict adherence to the recommended treatment regimen.

continue: Antidepressant Medications


Antidepressant Medications

Major depression, the kind of depression that will most likely benefit from treatment with medications, is more than just "the blues." It is a condition that lasts 2 weeks or more, and interferes with a person's ability to carry on daily tasks and enjoy activities that previously brought pleasure. Depression is associated with abnormal functioning of the brain. An interaction between genetic tendency and life history appears to determine a person's chance of becoming depressed. Episodes of depression may be triggered by stress, difficult life events, side effects of medications, or medication/substance withdrawal, or even viral infections that can affect the brain.

Depressed people will seem sad, or "down," or may be unable to enjoy their normal activities. They may have no appetite and lose weight (although some people eat more and gain weight when depressed). They may sleep too much or too little, have difficulty going to sleep, sleep restlessly, or awaken very early in the morning. They may speak of feeling guilty, worthless, or hopeless; they may lack energy or be jumpy and agitated. They may think about killing themselves and may even make a suicide attempt. Some depressed people have delusions (false, fixed ideas) about poverty, sickness, or sinfulness that are related to their depression. Often feelings of depression are worse at a particular time of day, for instance, every morning or every evening.

Not everyone who is depressed has all these symptoms, but everyone who is depressed has at least some of them, co-existing, on most days. Depression can range in intensity from mild to severe. Depression can co-occur with other medical disorders such as cancer, heart disease, stroke, Parkinson's disease, Alzheimer's disease, and diabetes. In such cases, the depression is often overlooked and is not treated. If the depression is recognized and treated, a person's quality of life can be greatly improved.

Antidepressants are used most often for serious depressions, but they can also be helpful for some milder depressions. Antidepressants are not "uppers" or stimulants, but rather take away or reduce the symptoms of depression and help depressed people feel the way they did before they became depressed.


continue story below


The doctor chooses an antidepressant based on the individual's symptoms. Some people notice improvement in the first couple of weeks; but usually the medication must be taken regularly for at least 6 weeks and, in some cases, as many as 8 weeks before the full therapeutic effect occurs. If there is little or no change in symptoms after 6 or 8 weeks, the doctor may prescribe a different medication or add a second medication such as lithium, to augment the action of the original antidepressant. Because there is no way of knowing beforehand which medication will be effective, the doctor may have to prescribe first one and then another. To give a medication time to be effective and to prevent a relapse of the depression once the patient is responding to an antidepressant, the medication should be continued for 6 to 12 months, or in some cases longer, carefully following the doctor's instructions. When a patient and the doctor feel that medication can be discontinued, withdrawal should be discussed as to how best to taper off the medication gradually. Never discontinue medication without talking to the doctor about it. For those who have had several bouts of depression, long-term treatment with medication is the most effective means of preventing more episodes.

Dosage of antidepressants varies, depending on the type of drug and the person's body chemistry, age, and, sometimes, body weight. Traditionally, antidepressant dosages are started low and raised gradually over time until the desired effect is reached without the appearance of troublesome side effects. Newer antidepressants may be started at or near therapeutic doses.

Early Antidepressants. From the 1960s through the 1980s, tricyclic antidepressants (named for their chemical structure) were the first line of treatment for major depression. Most of these medications affected two chemical neurotransmitters, norepinephrine and serotonin. Though the tricyclics are as effective in treating depression as the newer antidepressants, their side effects are usually more unpleasant; thus, today tricyclics such as imipramine, amitriptyline, nortriptyline, and desipramine are used as a second- or third-line treatment. Other antidepressants introduced during this period were monoamine oxidase inhibitors (MAOIs). MAOIs are effective for some people with major depression who do not respond to other antidepressants. They are also effective for the treatment of panic disorder and bipolar depression. MAOIs approved for the treatment of depression are phenelzine (Nardil), tranylcypromine (Parnate), and isocarboxazid (Marplan). Because substances in certain foods, beverages, and medications can cause dangerous interactions when combined with MAOIs, people on these agents must adhere to dietary restrictions. This has deterred many clinicians and patients from using these effective medications, which are in fact quite safe when used as directed.

The past decade has seen the introduction of many new antidepressants that work as well as the older ones but have fewer side effects. Some of these medications primarily affect one neurotransmitter, serotonin, and are called >selective serotonin reuptake inhibitors (SSRIs). These include fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), and citalopram (Celexa).

The late 1990s ushered in new medications that, like the tricyclics, affect both norepinephrine and serotonin but have fewer side effects. These new medications include venlafaxine (Effexor) and nefazadone (Serzone).

Cases of life-threatening hepatic failure have been reported in patients treated with nefazodone (Serzone). Patients should call the doctor if the following symptoms of liver dysfunction occur—yellowing of the skin or white of eyes, unusually dark urine, loss of appetite that lasts for several days, nausea, or abdominal pain.

Other newer medications chemically unrelated to the other antidepressants are the sedating mirtazepine (Remeron) and the more activating bupropion (Wellbutrin). Wellbutrin has not been associated with weight gain or sexual dysfunction but is not used for people with, or at risk for, a seizure disorder.

Each antidepressant differs in its side effects and in its effectiveness in treating an individual person, but the majority of people with depression can be treated effectively by one of these antidepressants.

continue: Side-Effects of Antidepressant Medications


Side Effects of Antidepressant Medications

Antidepressants may cause mild, and often temporary, side effects (sometimes referred to as adverse effects) in some people. Typically, these are not serious. However, any reactions or side effects that are unusual, annoying, or that interfere with functioning should be reported to the doctor immediately. The most common side effects of tricyclic antidepressants, and ways to deal with them, are as follows:

  • Dry mouth—it is helpful to drink sips of water; chew sugarless gum; brush teeth daily.
  • Constipation—bran cereals, prunes, fruit, and vegetables should be in the diet.
  • Bladder problems—emptying the bladder completely may be difficult, and the urine stream may not be as strong as usual. Older men with enlarged prostate conditions may be at particular risk for this problem. The doctor should be notified if there is any pain.
  • Sexual problems—sexual functioning may be impaired; if this is worrisome, it should be discussed with the doctor.
  • Blurred vision—this is usually temporary and will not necessitate new glasses. Glaucoma patients should report any change in vision to the doctor.
  • Dizziness—rising from the bed or chair slowly is helpful.
  • Drowsiness as a daytime problem—this usually passes soon. A person who feels drowsy or sedated should not drive or operate heavy equipment. The more sedating antidepressants are generally taken at bedtime to help sleep and to minimize daytime drowsiness.
  • Increased heart rate—pulse rate is often elevated. Older patients should have an electrocardiogram (EKG) before beginning tricyclic treatment.

The newer antidepressants, including SSRIs, have different types of side effects, as follows:


continue story below


  • Sexual problems—fairly common, but reversible, in both men and women. The doctor should be consulted if the problem is persistent or worrisome.
  • Headache—this will usually go away after a short time.
  • Nausea—may occur after a dose, but it will disappear quickly.
  • Nervousness and insomnia (trouble falling asleep or waking often during the night)—these may occur during the first few weeks; dosage reductions or time will usually resolve them.
  • Agitation (feeling jittery)—if this happens for the first time after the drug is taken and is more than temporary, the doctor should be notified.
  • Any of these side effects may be amplified when an SSRI is combined with other medications that affect serotonin. In the most extreme cases, such a combination of medications (e.g., an SSRI and an MAOI) may result in a potentially serious or even fatal "serotonin syndrome," characterized by fever, confusion, muscle rigidity, and cardiac, liver, or kidney problems.

The small number of people for whom MAOIs are the best treatment need to avoid taking decongestants and consuming certain foods that contain high levels of tyramine, such as many cheeses, wines, and pickles. The interaction of tyramine with MAOIs can bring on a sharp increase in blood pressure that can lead to a stroke. The doctor should furnish a complete list of prohibited foods that the individual should carry at all times. Other forms of antidepressants require no food restrictions. MAOIs also should not be combined with other antidepressants, especially SSRIs, due to the risk of serotonin syndrome.

Medications of any kind—prescribed, over-the-counter, or herbal supplements—should never be mixed without consulting the doctor; nor should medications ever be borrowed from another person. Other health professionals who may prescribe a drug—such as a dentist or other medical specialist—should be told that the person is taking a specific antidepressant and the dosage. Some drugs, although safe when taken alone, can cause severe and dangerous side effects if taken with other drugs. Alcohol (wine, beer, and hard liquor) or street drugs, may reduce the effectiveness of antidepressants and their use should be minimized or, preferably, avoided by anyone taking antidepressants. Some people who have not had a problem with alcohol use may be permitted by their doctor to use a modest amount of alcohol while taking one of the newer antidepressants. The potency of alcohol may be increased by medications since both are metabolized by the liver; one drink may feel like two.

Although not common, some people have experienced withdrawal symptoms when stopping an antidepressant too abruptly. Therefore, when discontinuing an antidepressant, gradual withdrawal is generally advisable.

Questions about any antidepressant prescribed, or problems that may be related to the medication, should be discussed with the doctor and/or the pharmacist.

continue: Antianxiety Medications


Antianxiety Medications

Everyone experiences anxiety at one time or another — "butterflies in the stomach" before giving a speech or sweaty palms during a job interview are common symptoms. Other symptoms include irritability, uneasiness, jumpiness, feelings of apprehension, rapid or irregular heartbeat, stomachache, nausea, faintness, and breathing problems.

Anxiety is often manageable and mild, but sometimes it can present serious problems. A high level or prolonged state of anxiety can make the activities of daily life difficult or impossible. People may have generalized anxiety disorder (GAD) or more specific anxiety disorders such as panic, phobias, obsessive-compulsive disorder (OCD), or post-traumatic stress disorder (PTSD).

Both antidepressants and antianxiety medications are used to treat anxiety disorders. The broad-spectrum activity of most antidepressants provides effectiveness in anxiety disorders as well as depression. The first medication specifically approved for use in the treatment of OCD was the tricyclic antidepressant clomipramine (Anafranil). The SSRIs, fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft) have now been approved for use with OCD. Paroxetine has also been approved for social anxiety disorder (social phobia), GAD, and panic disorder; and sertraline is approved for panic disorder and PTSD. Venlafaxine (Effexor) has been approved for GAD.

Antianxiety medications include the benzodiazepines, which can relieve symptoms within a short time. They have relatively few side effects: drowsiness and loss of coordination are most common; fatigue and mental slowing or confusion can also occur. These effects make it dangerous for people taking benzodiazepines to drive or operate some machinery. Other side effects are rare.

Benzodiazepines vary in duration of action in different people; they may be taken two or three times a day, sometimes only once a day, or just on an "as-needed" basis. Dosage is generally started at a low level and gradually raised until symptoms are diminished or removed. The dosage will vary a great deal depending on the symptoms and the individual's body chemistry.


continue story below


It is wise to abstain from alcohol when taking benzodiazepines, because the interaction between benzodiazepines and alcohol can lead to serious and possibly life-threatening complications. It is also important to tell the doctor about other medications being taken.

People taking benzodiazepines for weeks or months may develop tolerance for and dependence on these drugs. Abuse and withdrawal reactions are also possible. For these reasons, the medications are generally prescribed for brief periods of time—days or weeks—and sometimes just for stressful situations or anxiety attacks. However, some patients may need long-term treatment.

It is essential to talk with the doctor before discontinuing a benzodiazepine. A withdrawal reaction may occur if the treatment is stopped abruptly. Symptoms may include anxiety, shakiness, headache, dizziness, sleeplessness, loss of appetite, or in extreme cases, seizures. A withdrawal reaction may be mistaken for a return of the anxiety because many of the symptoms are similar. After a person has taken benzodiazepines for an extended period, the dosage is gradually reduced before it is stopped completely. Commonly used benzodiazepines include clonazepam (Klonopin), alprazolam (Xanax), diazepam (Valium), and lorazepam (Ativan).

The only medication specifically for anxiety disorders other than the benzodiazepines is buspirone (BuSpar). Unlike the benzodiazepines, buspirone must be taken consistently for at least 2 weeks to achieve an antianxiety effect and therefore cannot be used on an "as-needed" basis.

Beta blockers, medications often used to treat heart conditions and high blood pressure, are sometimes used to control "performance anxiety" when the individual must face a specific stressful situation—a speech, a presentation in class, or an important meeting. Propranolol (Inderal, Inderide) is a commonly used beta blocker.

continue: Psychiatric Medications for Children, the Elderly and Pregnant Women


Medications for Special Groups

Children, the elderly, and pregnant and nursing women have special concerns and needs when taking psychotherapeutic medications. Some effects of medications on the growing body, the aging body, and the childbearing body are known, but much remains to be learned. Research in these areas is ongoing.

In general, the information throughout this booklet applies to these groups, but the following are a few special points to keep in mind.

Children

The 1999 MECA Study (Methodology for Epidemiology of Mental Disorders in Children and Adolescents) estimated that almost 21 percent of U.S. children ages 9 to 17 had a diagnosable mental or addictive disorder that caused at least some impairment. When diagnostic criteria were limited to significant functional impairment, the estimate dropped to 11 percent, for a total of 4 million children who suffer from a psychiatric disorder that limits their ability to function.6

It is easy to overlook the seriousness of childhood mental disorders. In children, these disorders may present symptoms that are different from or less clear-cut than the same disorders in adults. Younger children, especially, and sometimes older children as well, may not talk about what is bothering them. For this reason, it is important to have a doctor, another mental health professional, or a psychiatric team examine the child.

Many treatments are available to help these children. The treatments include both medications and psychotherapy—behavioral therapy, treatment of impaired social skills, parental and family therapy, and group therapy. The therapy used is based on the child's diagnosis and individual needs.

When the decision is reached that a child should take medication, active monitoring by all caretakers (parents, teachers, and others who have charge of the child) is essential. Children should be watched and questioned for side effects because many children, especially younger ones, do not volunteer information. They should also be monitored to see that they are actually taking the medication and taking the proper dosage on the correct schedule.


continue story below


Childhood-onset depression and anxiety are increasingly recognized and treated. However, the best-known and most-treated childhood-onset mental disorder is attention deficit hyperactivity disorder (ADHD). Children with ADHD exhibit symptoms such as short attention span, excessive motor activity, and impulsivity which interfere with their ability to function especially at school. The medications most commonly prescribed for ADHD are called stimulants. These include methylphenidate (Ritalin, Metadate, Concerta), amphetamine (Adderall), dextroamphetamine (Dexedrine, Dextrostat), and pemoline (Cylert). Because of its potential for serious side effects on the liver, pemoline is not ordinarily used as a first-line therapy for ADHD. Some antidepressants such as bupropion (Wellbutrin) are often used as alternative medications for ADHD for children who do not respond to or tolerate stimulants.

Based on clinical experience and medication knowledge, a physician may prescribe to young children a medication that has been approved by the FDA for use in adults or older children. This use of the medication is called "off-label." Most medications prescribed for childhood mental disorders, including many of the newer medications that are proving helpful, are prescribed off-label because only a few of them have been systematically studied for safety and efficacy in children. Medications that have not undergone such testing are dispensed with the statement that "safety and efficacy have not been established in pediatric patients." The FDA has been urging that products be appropriately studied in children and has offered incentives to drug manufacturers to carry out such testing. The National Institutes of Health and the FDA are examining the issue of medication research in children and are developing new research approaches.

The use of the other medications described in this booklet is more limited with children than with adults. Therefore, a special list of medications for children, with the ages approved for their use, appears immediately after the general list of medications. Also listed are NIMH publications with more information on the treatment of both children and adults with mental disorders.

continue: Psychiatric Medications for the Elderly and Women Before and During Pregnancy


The Elderly

Persons over the age of 65 make up almost 13 percent of the population of the United States, but they receive 30 percent of prescriptions filled. The elderly generally have more medical problems, and many of them are taking medications for more than one of these conditions. In addition, they tend to be more sensitive to medications. Even healthy older people eliminate some medications from the body more slowly than younger persons and therefore require a lower or less frequent dosage to maintain an effective level of medication.

The elderly are also more likely to take too much of a medication accidentally because they forget that they have taken a dose and take another one. The use of a 7-day pill-box, as described earlier in this brochure, can be especially helpful for an elderly person.

The elderly and those close to them—friends, relatives, caretakers—need to pay special attention and watch for adverse (negative) physical and psychological responses to medication. Because they often take more medications—not only those prescribed but also over-the-counter preparations and home, folk, or herbal remedies—the possibility of adverse drug interactions is high.

Women During the Childbearing Years

Because there is a risk of birth defects with some psychotropic medications during early pregnancy, a woman who is taking such medication and wishes to become pregnant should discuss her plans with her doctor. In general, it is desirable to minimize or avoid the use of medication during early pregnancy. If a woman on medication discovers that she is pregnant, she should contact her doctor immediately. She and the doctor can decide how best to handle her therapy during and following the pregnancy. Some precautions that should be taken are:7


continue story below


  • If possible, lithium should be discontinued during the first trimester (first 3 months of pregnancy) because of an increased risk of birth defects.
  • If the patient has been taking an anticonvulsant such as carbamazepine (Tegretol) or valproic acid (Depakote)—both of which have a somewhat higher risk than lithium—an alternate treatment should be used if at all possible. The risks of two other anticonvulsants, lamotrigine (Lamictal) and gabapentin (Neurontin) are unknown. An alternative medication for any of the anticonvulsants might be a conventional antipsychotic or an antidepressant, usually an SSRI. If essential to the patient's health, an anticonvulsant should be given at the lowest dose possible. It is especially important when taking an anticonvulsant to take a recommended dosage of folic acid during the first trimester.
  • Benzodiazepines are not recommended during the first trimester.

The decision to use a psychotropic medication should be made only after a careful discussion between the woman, her partner, and her doctor about the risks and benefits to her and the baby. If, after discussion, they agree it best to continue medication, the lowest effective dosage should be used, or the medication can be changed. For a woman with an anxiety disorder, a change from a benzodiazepine to an antidepressant might be considered. Cognitive-behavioral therapy may be beneficial in helping an anxious or depressed person to lower medication requirements. For women with severe mood disorders, a course of electroconvulsive therapy (ECT) is sometimes recommended during pregnancy as a means of minimizing exposure to riskier treatments.

After the baby is born, there are other considerations. Women with bipolar disorder are at particularly high risk for a postpartum episode. If they have stopped medication during pregnancy, they may want to resume their medication just prior to delivery or shortly thereafter. They will also need to be especially careful to maintain their normal sleep-wake cycle. Women who have histories of depression should be checked for recurrent depression or postpartum depression during the months after the birth of a child.

Women who are planning to breastfeed should be aware that small amounts of medication pass into the breast milk. In some cases, steps can be taken to reduce the exposure of the nursing infant to the mother's medication, for instance, by timing doses to post-feeding sleep periods. The potential benefits and risks of breastfeeding by a woman taking psychotropic medication should be discussed and carefully weighed by the patient and her physician.

A woman who is taking birth control pills should be sure that her doctor knows this. The estrogen in these pills may affect the breakdown of medications by the body—for example, increasing side effects of some antianxiety medications or reducing their ability to relieve symptoms of anxiety. Also, some medications, including carbamazepine and some antibiotics, and an herbal supplement, St. John's wort, can cause an oral contraceptive to be ineffective.

continue: List of all Psychiatric Medications


Index of Medications

To find the section of the text that describes a particular medication in the lists below, find the generic trade (brand) name and look it up on the second list. If the name of the medication does not appear on the prescription label, ask the doctor or pharmacist for it. (Note: Some drugs are marketed under numerous trade names, not all of which can be listed in a short publication like this one. If your medication's trade name does not appear in the list—and some older medicines are no longer listed by trade names—look it up by its generic name or ask your doctor or pharmacist for more information. Stimulant medications that are used by both children and adults with ADHD are listed in the children's medications chart). (chemical) name and look it up on the first list or find the

Alphabetical List of Psychiatric Medications by Generic Name8

Generic NameTrade Name

Combination Antipsychotic and Antidepressant Medication

Symbyax (Prozac & Zyprexa) fluoxetine & olanzapine

Antipsychotic Medications

aripiprazole Abilify
chlorpromazine Thorazine
chlorprothixene Taractan
clozapine Clozaril
fluphenazine Permitil, Prolixin
haloperidol Haldol
loxapine Loxitane
mesoridazine Serentil
molindone Lidone, Moban
olanzapine Zyprexa
perphenazine Trilafon
pimozide (for Tourette's syndrome) Orap
quetiapine Seroquel
risperidone Risperdal
thioridazine Mellaril
thiothixene Navane
trifluoperazine Stelazine
trifluopromazine Vesprin
ziprasidone Geodon
Antimanic Medications
carbamazepine Tegretol
divalproex sodium (valproic acid) Depakote
gabapentin Neurontin
lamotrigine Lamictal
lithium carbonate Eskalith, Lithane, Lithobid
lithium citrate Cibalith-S
topimarate Topamax

Antidepressant Medications

amitriptyline Elavil
amoxapine Asendin
bupropion Wellbutrin
citalopram (SSRI) Celexa
clomipramine Anafranil
desipramine Norpramin, Pertofrane
doxepin Adapin, Sinequan
escitalopram (SSRI) Lexapro
fluvoxamine (SSRI) Luvox
fluoxetine (SSRI) Prozac
imipramine Tofranil
isocarboxazid (MAOI) Marplan
maprotiline Ludiomil
mirtazapine Remeron
nefazodone Serzone
nortriptyline Aventyl, Pamelor
paroxetine (SSRI) Paxil
phenelzine (MAOI) Nardil
protriptyline Vivactil
sertraline (SSRI) Zoloft
tranylcypromine (MAOI) Parnate
trazodone Desyrel
trimipramine Surmontil
venlafaxine Effexor

Antianxiety Medications

(All of these antianxiety medications except buspirone are benzodiazepines)
alprazolam Xanax
buspirone BuSpar
chlordiazepoxide Librax, Libritabs, Librium
clonazepam Klonopin
clorazepate Azene, Tranxene
diazepam Valium
halazepam Paxipam
lorazepam Ativan
oxazepam Serax
prazepam Centrax

continue story below


continue: List of Psychiatric Medications by Trade Name


Alphabetical List of Psychiatric Medications by Trade Name

Trade NameGeneric Name
Combination Antipsychotic and Antidepressant Medication
fluoxetine & olanzapine Symbyax (Prozac & Zyprexa)
Antipsychotic Medications
Abilify aripiprazole
Clozaril clozapine
Geodon ziprasidone
Haldol haloperidol
Lidone molindone
Loxitane loxapine
Mellaril thioridazine
Moban molindone
Navane thiothixene
Orap (for Tourette's syndrome) pimozide
Permitil fluphenazine
Prolixin fluphenazine
Risperdal risperidone
Serentil mesoridazine
Seroquel quetiapine
Stelazine trifluoperazine
Taractan chlorprothixene
Thorazine chlorpromazine
Trilafon perphenazine
Vesprin trifluopromazine
Zyprexa olanzapine
Antimanic Medications
Cibalith-S lithium citrate
Depakote valproic acid, divalproex sodium
Eskalith lithium carbonate
Lamictal lamotrigine
Lithane lithium carbonate
Lithobid lithium carbonate
Neurontin gabapentin
Tegretol carbamazepine
Topamax topiramate
Antidepressant Medications
Adapin doxepin
Anafranil clomipramine
Asendin amoxapine
Aventyl nortriptyline
Celexa (SSRI) citalopram
Desyrel trazodone
Effexor venlafaxine
Elavil amitriptyline
Lexapro (SSRI) escitalopram
Ludiomil maprotiline
Luvox (SSRI) fluvoxamine
Marplan (MAOI) isocarboxazid
Nardil (MAOI) phenelzine
Norpramin desipramine
Pamelor nortriptyline
Parnate (MAOI) tranylcypromine
Paxil (SSRI) paroxetine
Pertofrane desipramine
Prozac (SSRI) fluoxetine
Remeron mirtazapine
Serzone nefazodone
Sinequan doxepin
Surmontil trimipramine
Tofranil imipramine
Vivactil protriptyline
Wellbutrin bupropion
Zoloft (SSRI) sertraline
Antianxiety Medications
(All of these antianxiety medications except BuSpar are benzodiazepines)
Ativan lorazepam
Azene clorazepate
BuSpar buspirone
Centrax prazepam
Librax, Libritabs, Librium chlordiazepoxide
Klonopin clonazepam
Paxipam halazepam
Serax oxazepam
Tranxene clorazepate
Valium diazepam
Xanax alprazolam

continue story below


continue: List of Children's Psychiatric Medications


Children's Psychiatric Medication Chart

Trade NameGeneric NameApproved Age
Stimulant Medications
Adderall amphetamine 3 and older
Adderall XR amphetamine
(extended release)
6 and older
Concerta methylphenidate
(long acting)
6 and older
Cylert* pemoline 6 and older
Dexedrine dextroamphetamine 3 and older
Dextrostat dextroamphetamine 3 and older
Focalin dexmethylphenidate 6 and older
Metadate ER methylphenidate
(extended release)
6 and older
Ritalin methylphenidate 6 and older
*Because of its potential for serious side effects affecting the liver, Cylert should not
ordinarily be considered as first-line drug therapy for ADHD.
Non-stimulant for ADHD
Strattera atomoxetine 6 and older
Antidepressant and Antianxiety Medications
Anafranil clomipramine 10 and older (for OCD)
BuSpar buspirone 18 and older
Effexor venlafaxine 18 and older
Luvox (SSRI) fluvoxamine 8 and older (for OCD)
Paxil (SSRI) paroxetine 18 and older
Prozac (SSRI) fluoxetine 18 and older
Serzone (SSRI) nefazodone 18 and older
Sinequan doxepin 12 and older
Tofranil imipramine 6 and older (for bedwetting)
Wellbutrin bupropion 18 and older
Zoloft (SSRI) sertraline 6 and older (for OCD)
Antipsychotic Medications
Clozaril (atypical) clozapine 18 and older
Haldol haloperidol 3 and older
Risperdal (atypical) risperidone 18 and older
Seroquel (atypical) quetiapine 18 and older
Mellaril thioridazine 2 and older
Zyprexa (atypical) olanzapine 18 and older
Orap pimozide 12 and older (for Tourette's
syndrome—Data for age 2 and
older indicate similar safety profile)
Mood Stabilizing Medications
Cibalith-S lithium citrate 12 and older
Depakote valproic acid 2 and older (for seizures)
Eskalith lithium carbonate 12 and older
Lithobid lithium carbonate 12 and older
Tegretol carbamazepine any age (for seizures)

continue story below


continue: Important Warnings When Using Antidepressant Medications


References

1. Fenton WS. Prevalence of spontaneous dyskinesia in schizophrenia. Journal of Clinical Psychiatry, 2000; 62 (suppl 4): 10-14.

2. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. For the Divalproex Maintenance Study Group. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Archives of General Psychiatry, 2000; 57(5): 481-489.

3. Vainionpää LK, Rättyä J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology, 1999; 45(4): 444-450.

4. Soames JC. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries. Bipolar Disorder, 2000; 2(1): 37-41.

5. Thase ME, and Sachs GS. Bipolar depression: Pharmacotherapy and related therapeutic strategies. Biological Psychiatry, 2000; 48(6): 558-572.

6. Department of Health and Human Services. 1999. Mental Health: A Report of the Surgeon General. Rockville, MD: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institute of Mental Health.

7. Altshuler LL, Cohen L, Szuba MP, Burt VK, Gitlin M, and Mintz J. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines. American Journal of Psychiatry, 1996; 153(5): 592-606.

8. Physicians' Desk Reference, 54th edition. Montavale, NJ: Medical Economics Data Production Co. 2000.

Addendum (January 2007)

This addendum to the booklet Medications for Mental Illness (2005) was prepared to provide updated information on medications in the booklet and results of recent research on medications. This addendum also applies to the Medications Web page document.

Antidepressant Medications

Nefazodone — brand name Serzone

The manufacturer discontinued sales of the antidepressant in the U.S. effective June 14, 2004.


continue story below


FDA Warnings and Antidepressant Medications

Despite the relative safety and popularity of SSRIs and other antidepressants, some studies have suggested that they may have unintentional effects on some people, especially adolescents and young adults. In 2004, the Food and Drug Administration (FDA) conducted a thorough review of published and unpublished controlled clinical trials of antidepressants that involved nearly 4,400 children and adolescents. The review revealed that 4% of those taking antidepressants thought about or attempted suicide (although no suicides occurred), compared to 2% of those receiving placebos.

This information prompted the FDA, in 2005, to adopt a "black box" warning label on all antidepressant medications to alert the public about the potential increased risk of suicidal thinking or attempts in children and adolescents taking antidepressants. In 2007, the FDA proposed that makers of all antidepressant medications extend the warning to include young adults up through age 24. A "black box" warning is the most serious type of warning on prescription drug labeling.

The warning emphasizes that patients of all ages taking antidepressants should be closely monitored, especially during the initial weeks of treatment. Possible side effects to look for are worsening depression, suicidal thinking or behavior, or any unusual changes in behavior such as sleeplessness, agitation, or withdrawal from normal social situations. The warning adds that families and caregivers should also be told of the need for close monitoring and report any changes to the physician. The latest information from the FDA can be found on their Web site at www.fda.gov.

Results of a comprehensive review of pediatric trials conducted between 1988 and 2006 suggested that the benefits of antidepressant medications likely outweigh their risks to children and adolescents with major depression and anxiety disorders.28 The study was funded in part by the National Institute of Mental Health.

Also, the FDA issued a warning that combining an SSRI or SNRI antidepressant with one of the commonly-used "triptan" medications for migraine headache could cause a life-threatening "serotonin syndrome," marked by agitation, hallucinations, elevated body temperature, and rapid changes in blood pressure. Although most dramatic in the case of the MAOIs, newer antidepressants may also be associated with potentially dangerous interactions with other medications.

continue: Important Warnings When Using Antipsychotic Medications


Antipsychotic Medications

Below are further details concerning side effects of antipsychotic medications found on pages 5 and 6 in the original Medications for Mental Illness booklet. The medications discussed below are primarily used to treat schizophrenia or other psychotic disorders.

The typical (conventional) antipsychotic medications include chlorpromazine (Thorazine®), haloperidol (Haldol®), perphenazine (Etrafon, Trilafon®), and fluphenzine (Prolixin®). The typical medications can cause extrapyramidal side effects, such as rigidity, persistent muscle spasms, tremors, and restlessness.

In the 1990s, atypical (second generation) antipsychotics were developed that are less likely to produce these side effects. The first of these was clozapine (Clozaril®, Prolixin®), introduced in 1990. It treats psychotic symptoms effectively even in people who do not respond to other medications. However, it can produce a serious but rare problem called agranulocytosis, a loss of the white blood cells that fight infection. Therefore, patients who take clozapine must have their white blood cell counts monitored every week or two. The inconvenience and cost of both the blood tests and the medication itself has made treatment with clozapine difficult for many people, but it is the drug of choice for those whose symptoms do not respond to other typical and atypical antipsychotic medications.

After clozapine was introduced, other atypical antipsychotics were developed, such as risperidone (Risperdal®), olanzapine (Zyprexa®), quietiapine (Seroquel®) and ziprasidone (Geodon®). The newest atypicals include aripiprazole (Abilify®) and paliperidone (Invega®). All are effective and are less likely to produce extrapyramidal symptoms or agranulocytosis. However, they can cause weight gain, which may result in an increased risk of diabetes and high cholesterol level.1,2

The FDA has determined that the treatment of behavioral disorders in elderly patients with atypical (second generation) antipsychotic medications is associated with increased mortality. These medications are not approved by the FDA for the treatment of behavioral disorders in patients with dementia.


continue story below


Children and Psychiatric Medications

In October 2006, the FDA approved risperidone (Risperdal®) for the symptomatic treatment of irritability in autistic children and adolescents ages 5 to 16. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability, and include aggression, deliberate self-injury and temper tantrums.

Fluoxetine (Prozac®) and sertraline (Zoloft®) are approved by the FDA for children age 7 and older with obsessive-compulsive disorder. Fluoxetine is also approved for children age 8 and older for the treatment of depression. Fluoxetine and sertraline are selective serotonin reuptake inhibitors (SSRIs). See above for the (FDA) warning concerning SSRIs and other antidepressants.

Research on Medications

In recent years, NIMH has conducted large scale clinical trials to identify effective treatments for schizophrenia, depression, and bipolar disorder. Researchers also wanted to determine the long- term success of different treatments and provide options for patients and clinicians that are based on sound research. The studies were held in many sites across the country to reflect the diversity of real world clinical settings. Details about these studies can be found by clicking on the links below. As additional information about the results of these studies becomes available, updates will be added to the NIMH Web site.

Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE)
CATIE compared the effectiveness of typical antipsychotic medications (first available in the 1950s) and atypical antipsychotic medications (available since the 1990s) used to treat schizophrenia.

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
The main goal of STAR*D was to identify the best "next steps" for people with depression who need to try more than one treatment when the first does not work.

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
STEP-BD aimed to obtain long-term data on the chronic, recurrent course of bipolar disorder; identify the best treatments for those with the disorder; obtain data for predicting recurrence of a manic or depressive episode; and study whether adding any one of three medications improved the outcomes for patients with treatment-resistant bipolar disorder.

Treatments for Adolescents with Depression Study (TADS)
TADS compared the use of cognitive-behavioral therapy (CBT) alone, medication (fluoxetine) alone, or a combination of both treatments in adolescents with depression.

These studies provide answers to many, but not all questions about treatment options and help further the understanding of these disorders. NIMH will continue to investigate various approaches to understanding these and other disorders, as well as identify treatments that meet the individual needs of patients.

continue: List of Antidepressant Medications with Black Box Warnings


List of Antidepressant Medications

List of drugs receiving a "black box" warning, other product labeling changes, and a Medication Guide pertaining to pediatric suicidality:

    • Anafranil (clomipramine)
    • Asendin (amoxapine)
    • Aventyl (nortriptyline)
    • Celexa (citalopram hydrobromide)
    • Cymbalta (duloxetine)
    • Desyrel (trazodone HCl)
    • Effexor (venlafaxine HCl)
    • Elavil (amitriptyline)
    • Etrafon (perphenazine/amitriptyline)
    • fluvoxamine maleate
    • Lexapro (escitalopram hydrobromide)
    • Limbitrol (chlordiazepoxide/amitriptyline)
    • Ludiomil (maprotiline)
    • Marplan (isocarboxazid)
    • Nardil (phenelzine sulfate)
    • Norpramin (desipramine HCl)
    • Pamelor (nortriptyline)
    • Parnate (tranylcypromine sulfate)
    • Paxil (paroxetine HCl)
    • Pexeva (paroxetine mesylate)
    • Prozac (fluoxetine HCl)
    • Remeron (mirtazapine)
    • Sarafem (fluoxetine HCl)
    • Serzone (nefazodone HCl)
    • Sinequan (doxepin)

continue story below


  • Surmontil (trimipramine)
  • Symbyax (olanzapine/fluoxetine)
  • Tofranil (imipramine)
  • Tofranil-PM (imipramine pamoate)
  • Triavil (perphenazine/amitriptyline)
  • Vivactil (protriptyline)
  • Wellbutrin (bupropion HCl)
  • Zoloft (sertraline HCl)
  • Zyban (bupropion HCl)

For comprehensive information on psychiatric medications visit the HealthyPlace.com Psychiatric Medications Pharmacology Center here.

Addendum References

1Marder SR, Essock SM, Miller AL, et al. Physical Health Monitoring of Patients With Schizophrenia. Am J Psychiatry. August 2004;161(8):1334-1349.

2Newcomer JW. Clinical considerations in selecting and using atypical antipsychotics. CNS Spect. Aug 2005;10(8 Suppl 8):12-20.

Source: National Institute of Mental Health (NIMH) Medications Publication. Updated June 2008.

back to: Psychiatric Disorders Definitions Index

APA Reference
Staff, H. (2009, January 2). Psychiatric Medications: Medications for Mental Illness, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/other-info/psychiatric-disorder-definitions/medications-for-mental-illness

Last Updated: March 29, 2017

Chapter 9: An AA Sponsor

For sufferers, survivors of alcoholism, drug abuse, substance abuse, gambling, other addictions. Expert information, addictions support groups, chat, journals, and support lists.

STEP 4: Made a searching and fearless inventory of ourselves. I would definitely recommend an AA sponsor to help you with this step. You can get yourself into quite a confusing quagmire if you try this step alone. You may need to be advised by your fellow AA members that you need to work on the first three steps more before you do step four. Personally, I would recommend having a bare minimum of 30 days sober while attending daily AA meetings before attempting step four. Many individuals need longer. Your AA sponsor may want you to do a rough draft of step four before you are ready. It's OK to do this, but do not consider yourself done forever. This is a life-changing program and lives do not change overnight.

My sponsor made me make a list of everything I had ever done in my life that I felt guilty of first. Then we went to the Alcoholics Anonymous book and read chapter five carefully. Simple instructions with an example tell you how to map out step four for your resentments, fear, and sexual conduct. Step four did not move me further from a drink in itself, but prepared me for the future steps that would enable me to continue to live without the compulsion to drink.

next: Stanton Peele Addiction Website
~ all Raw Psychology articles
~ addictions library articles
~ all addictions articles

APA Reference
Staff, H. (2009, January 2). Chapter 9: An AA Sponsor, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/addictions/articles/chapter-9-an-aa-sponsor

Last Updated: April 26, 2019

FAQ: Cost-Effectiveness of Drug Treatment

11. Is drug addiction treatment worth its cost?

addiction-articles-102-healthyplaceDrug addiction treatment is cost-effective in reducing drug use and its associated health and social costs. Treatment is less expensive than alternatives, such as not treating drug addicts or simply incarcerating addicts. For example, the average cost for 1 full year of methadone maintenance treatment is approximately $4,700 per patient, whereas 1 full year of imprisonment costs approximately $18,400 per person.

Drug addiction treatment is cost-effective in reducing drug use and its associated health and social costs.

According to several conservative estimates, every $1 invested in drug addiction treatment programs yields a return of between $4 and $7 in reduced drug-related crime, criminal justice costs, and theft alone. When savings related to health care are included, total savings can exceed costs by a ratio of 12 to 1. Major savings to the individual and society also come from significant drops in interpersonal conflicts, improvements in workplace productivity, and reductions in drug-related accidents.

National Institute of Drug Abuse, "Principles of Drug Addiction Treatment: A Research Based Guide."

next: Drug Addiction Treatment in the U.S.
~ all articles on Principles of Drug Addiction Treatment
~ addictions library articles
~ all addictions articles

APA Reference
Staff, H. (2009, January 2). FAQ: Cost-Effectiveness of Drug Treatment, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/addictions/articles/is-drug-addiction-treatment-worth-cost

Last Updated: April 26, 2019

Mental Health Bill Of Rights

Mental health patient rights agreed to by major organizations representing psychiatrists, psychologists, and other mental health therapists.

Mental health patient rights agreed to by major organizations representing psychiatrists, psychologists, and other mental health therapists.

A Joint Initiative of Mental Health Professional Organizations

Principles for the Provision of Mental Health and Substance Abuse Treatment Services A Bill of Rights

Our commitment is to provide quality mental health and substance abuse services to all individuals without regard to race, color, religion, national origin, gender, age, sexual orientation, or disabilities.

Right to Know

Benefits

Individuals have the right to be provided information from the purchasing entity (such as employer or union or public purchaser) and the insurance/third party payer describing the nature and extent of their mental health and substance abuse treatment benefits. This information should include details on procedures to obtain access to services, on utilization management procedures, and on appeal rights. The information should be presented clearly in writing with language that the individual can understand.

Professional Expertise

Individuals have the right to receive full information from the potential treating professional about that professional's knowledge, skills, preparation, experience, and credentials. Individuals have the right to be informed about the options available for treatment interventions and the effectiveness of the recommended treatment.

Contractual Limitations

Individuals have the right to be informed by the treating professional of any arrangements, restrictions, and/or covenants established between third party payer and the treating professional that could interfere with or influence treatment recommendations. Individuals have the right to be informed of the nature of information that may be disclosed for the purposes of paying benefits.

Appeals and Grievances

Individuals have the right to receive information about the methods they can use to submit complaints or grievances regarding provision of care by the treating professional to that profession's regulatory board and to the professional association.

Individuals have the right to be provided information about the procedures they can use to appeal benefit utilization decisions to the third party payer systems, to the employer or purchasing entity, and to external regulatory entities.

Confidentiality

Individuals have the right to be guaranteed the protection of the confidentiality of their relationship with their mental health and substance abuse professional, except when laws or ethics dictate otherwise. Any disclosure to another party will be time limited and made with the full written, informed consent of the individuals. Individuals shall not be required to disclose confidential, privileged or other information other than: diagnosis, prognosis, type of treatment, time and length of treatment, and cost.

Entities receiving information for the purposes of benefits determination, public agencies receiving information for health care planning, or any other organization with legitimate right to information will maintain clinical information in confidence with the same rigor and be subject to the same penalties for violation as is the direct provider of care.

Information technology will be used for transmission, storage, or data management only with methodologies that remove individual identifying information and assure the protection of the individual's privacy. Information should not be transferred, sold or otherwise utilized.

Choice

Individuals have the right to choose any duly licensed/certified professional for mental health and substance abuse services. Individuals have the right to receive full information regarding the education and training of professionals, treatment options (including risks and benefits), and cost implications to make an informed choice regarding the selection of care deemed appropriate by individual and professional.

Determination of Treatment

Recommendations regarding mental health and substance abuse treatment shall be made only by a duly licensed/certified professional in conjunction with the individual and his or her family as appropriate. Treatment decisions should not be made by third-party payers. The individual has the right to make final decisions regarding treatment.

Parity

Individuals have the right to receive benefits for mental health and substance abuse treatment on the same basis as they do for any other illnesses, with the same provisions, co-payments, lifetime benefits, and catastrophic coverage in both insurance and self-funded/self-insured health plans.

Discrimination

Individuals who use mental health and substance abuse benefits shall not be penalized when seeking other health insurance or disability, life or any other insurance benefit.

Benefit Usage

The individual is entitled to the entire scope of the benefits within the benefit plan that will address his or her clinical needs.

Benefit Design

Whenever both federal and state law and/or regulations are applicable, the professional and all payers shall use whichever affords the individual the greatest level of protection and access.

Treatment Review

To assure that treatment review processes are fair and valid, individuals have the right to be guaranteed that any review of their mental health and substance abuse treatment shall involve a professional having the training, credentials and licensure required to provide the treatment in the jurisdiction in which it will be provided. The reviewer should have no financial interest in the decision and is subject to the section on confidentiality.

Accountability

Treating professionals may be held accountable and liable to individuals for any injury caused by gross incompetence or negligence on the part of the professional. The treating professional has the obligation to advocate for and document necessity of care and to advise the individual of options if payment authorization is denied.

Payers and other third parties may be held accountable and liable to individuals for any injury caused by gross incompetence or negligence or by their clinically unjustified decisions.


Participating Groups:

American Association for Marriage and Family Therapy (membership: 25,000)
American Counseling Association (membership: 56,000)
American Family Therapy Academy (membership: (1,000)
American Nurses Association (membership: 180,000)
American Psychological Association (membership: 142,000)
American Psychiatric Association (membership: 36,000)
American Psychiatric Nurses Association (membership: 3,000)
National Association of Social Workers (membership: 155,000), National Federation of Societies for Clinical Social Work (membership: 11,000)

Supporting Groups:

Mental Health America.
National Depressive and Manic-Depressive Association
American Group Psychotherapy Association
American Psychoanalytic Association
National Association of Drug and Alcohol Abuse Counselors

APA Reference
Staff, H. (2009, January 2). Mental Health Bill Of Rights, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/other-info/psychiatric-disorder-definitions/mental-health-bill-of-rights

Last Updated: July 6, 2019

Powerful Beyond Measure! Or. . . What's This About Mid-life Crisis?

Perhaps there are some biological changes that go on as we grow older, however my experience has taught me that those years we call mid-life are often when most of us begin to be uncomfortable with the direction our lives are taking.

About Mid-life CrisisWe know there must be more than this! We begin to self-inquire and often are confronted by our own stuff; the stuff that isn't working, and somehow it seems we are powerless to choose another course of action.

Fear rears its ugly head. Some of us are afraid to change. We become anxious about the future.

What ever happened to "living in the present?"

We all have decisive and critical moments from time to time. A crisis or two now and then perhaps, but a crisis that ongoingly occupies an important part of our mid-life? Certainly we have learned by now that crises take our attention off of living life to its fullest. . . moment by moment.

It may even begin to dawn on us that we might be more than a bit responsible for what is happening to us right now. It is what we do differently to move us past these times that make the difference. Some people choose to hide out from life and do nothing. They quit trying. Seemingly puzzled, they watch life pass them by and wonder why.

The wise ones make some new choices. They begin to do something different.

Our deepest fear is not that we are inadequate to the task.

We begin to understand that this could be true.

Nelson Mandela said in his 1994 Inaugural Speech, "Our deepest fear is that we are powerful beyond measure!" That is scary for most of us. We notice that going for the small stuff or staying the same doesn't serve us or the world very well anymore. Not that it ever did. We notice when our needs are not being met and we are often doing little to help fulfill the needs of those closest to us; the ones we say we love. We appear to be distracted and disconnected from life.


continue story below


It happens to both men and women and in different ways for each. These are the unsettling years, and as they pass it is always interesting to see how long it will take us to break out of our self-imposed shell.

Perhaps a mid-life crisis is only a crisis we create, and it just happens to occur during the time we call mid-life. We are never quite sure when this is going to be and it is usually memorable. Could it be said that it is called a "mid-life crisis" because those times for many are so confusing, discouraging and relatively nonproductive. Now we know what crisis feels like. Refusing to take responsibility for our own choices, we feel relieved that we now have something on which to blame this phenomenon? Eureka! We even have a name for it!

Those who never seem to get past their fears to make new discoveries continue a so-called mid-life crisis and stay stuck in the misery they will not take responsibility for. It's scary when we begin to understand that we are the source of our own misery. Some people never reach that understanding.

As we are liberated from our fears, we love ourselves more. We start playing big, meaning: going for more and not settling for mediocrity; putting more into life and receiving more from it. We can now recognize that there might be other options. We feel good about discovering our greatest power. . . choice. The more we experience our many choices, the more grateful we become.

Not only that, when we begin to pay attention to what we are thinking and feeling about things and do those things differently, who we are often liberates those significant others, friends and family with whom we interact.

When people can understand the feelings they are having; where they come from, what causes them, who is responsible for them, who else might have influenced how they feel or how whatever happened might have happened. . . just the facts, it becomes easier to work through their stuff and get on with creating new and exciting possibilities. Those moments of understanding are truly enlightened moments. . . welcome them.

We really are powerful beyond measure.

It's time to demonstrate courage and love instead of fear. We all need to give ourselves permission to live our relationships powerfully. . . beyond measure.

One way is to live in the present. Live responsibly in the perfect present. Focus on now. Our true home is in the present moment. This is just one of the miracles we discover when we begin to let go of being right and all the other things that keep us living in the past. We are startled with a sense that letting go of our expectations might contribute to the cause of making the real magic of the moment appear!

Tell me what surprises you and I'll tell you how you are thinking.

What is refreshing, healing and empowering is this present moment. What we do in it either moves us in the direction of our calling or away from it. This is it! Reach out for "right now!" Touch this moment!

When we do this, touching this moment heals and transforms our lives. The past is gone. Accept it. The future lives in the present. Accept that too. One responsible choice at a time takes us from one moment to the other. Each tiny step will take us wherever we choose to go.

Live neither in the past nor in the future, but let every activity of the moment absorb all of your interest, energy and enthusiasm.

This is our best investment in ourselves and the relationships we have with others. When we live in the present, we live longer, happier and more satisfying lives. We have longer, happier and more satisfying relationships.

This has been my experience of crises that occur during mid-life.

I challenge you to discover what it is like to "live in the present!" Happiness, harmony and love reside there. Practice living moment by moment. Honor the opportunity you have to be a part of this very special moment. You live in it. Be present!

Knowledge is power only when we use it; for our own good and for the good of others. With it we can help others. Some have nearly lost hope and are ready to listen. They appear to be experiencing a self-created crisis somewhere during mid-life and seem to be unable to help themselves. Watch for clues that signal the opportunity to be somebody's angel. They may only need a gentle nudge.

They too, are powerful beyond measure!

next: The 10 "Commitments" of Networking

APA Reference
Staff, H. (2009, January 2). Powerful Beyond Measure! Or. . . What's This About Mid-life Crisis?, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/relationships/celebrate-love/powerful-beyond-measure-or-whats-this-about-mid-life-crisis

Last Updated: June 12, 2015

AA Abuse

Reason, November 1991, pp. 34-39

Under the influence of alcohol-treatment evangelists, courts, employers, and parents are forcing people into 12-step programs for the slightest of reasons.

Archie Brodsky
Boston, MA

Stanton Peele
Morristown, NJ

A high-level delegation from the Soviet Union recently visited Quincy, Massachusetts, to learn how District Court Judge Albert L. Kramer handles drunk drivers. Kramer routinely sentences first-time driving-while Intoxicated (DWI) offenders to Right Turn, a private treatment program for alcoholism that requires participants to attend Alcoholics Anonymous meetings. The Soviet visitors enthusiastically embraced Kramer's program, which is also a favorite of the American media.

One would think that the Soviets were ahead of us in therapeutic coercion, given their history of incarcerating political dissenters under bogus psychiatric labels. But from their perspective Kramer's approach is innovative: A.A. treatment is a process of spiritual conversion that requires submission to a "higher power" (a.k.a. God). By adopting compulsory A.A. treatment, the Soviets would be shifting from a policy of enforced atheism to one of enforced religion.

addiction-articles-106-healthyplaceAlcoholism treatment is today the standard sanction for DWI offenses in the United States, according to Constance Weisner of the Alcohol Research Group in Berkeley. "In fact, many states have transferred much of the handling of DWI offenses to alcohol treatment programs," she writes. In 1984, 2,551 public and private treatment programs in the United States reported providing DWI services for 864,000 individuals. In 1987, the 50 states devoted an average of 39 percent of their treatment units to DWI services. Some states continue to accelerate such treatment: From 1986 to 1988, Connecticut reported a 400-percent increase in the number of DWIs referred to treatment programs.

The response to drunk driving is part of the widespread American practice of forcing or pressuring people into A.A. style treatment. The courts (through sentencing, probation, and parole), government licensing and social-service agencies, and mainstream institutions such as schools and employers are pushing more than a million people into treatment each year. The use of coercion and pressure to fill the rolls of treatment programs has distorted the U.S. approach to substance abuse: The A.A. model, which uses a spiritual approach to treat the "disease" of alcoholism, would not have as pervasive an influence under conditions of free choice.

Furthermore, prescribing treatment as a substitute for normal criminal, social, or workplace sanctions represents a national revision of traditional notions of individual responsibility. When called to account for misbehavior, the criminal, the delinquent teenager, the malingering employee, or the abusive supervisor has an out: Alcohol (or drugs) made me do it. But in exchange for the seductive explanation that substance abuse causes antisocial behavior, we allow state intrusion in people's private lives. When we surrender responsibility, we lose our freedom as well.

Consider some of the ways in which people end up in treatment:

  • A major airline ordered a pilot into treatment after a fellow employee reported that he had twice been arrested for drunk driving a decade earlier. To keep his job and his FAA license, the pilot has to continue treatment indefinitely, despite an impeccable work record, no work-related drinking incidents, no drinking problems or DWI arrests for years, and a clean diagnosis by an independent clinician.
  • Helen Terry, a city employee in Vancouver, Washington, was ostracized on the job after she testified in support of a colleague's sexual-harassment suit. Terry never drank more than a glass of wine in the evening. Nonetheless, based on an unconfirmed report that she had drunk too much at a social event, her superiors ordered her to admit she was an alcoholic and enter a treatment center, under threat of dismissal. A court awarded her more than $200,000 in damages after she sued the city for wrongful discharge and denial of due process.
  • A man seeking to adopt a child admitted he had used drugs heavily almost a decade earlier. Required to submit to diagnosis, he was labeled "chemically dependent" even though he had not used drugs for years. Still awaiting the completion of the adoption process, he now worries that he will be followed for the rest of his life by the stigma of "chemical dependence."
  • States routinely require "impaired" physicians and attorneys to enter treatment to avoid having their licenses revoked. A certified addiction counselor for the American Bar Association's Commission on Impaired Attorneys reports: "I do an assessment and tell that person what they have to do to get well. Part of that component is A.A. They must attend A.A."

Alcoholics Anonymous was not always tied to coercion. It began in 1935 as a voluntary association among a handful of chronic alcoholics. Its roots were in the 19th-century temperance movement, as reflected in its confessional style and sin-and-salvation spirit. A.A., and the alcoholism-as-disease movement it inspired, translated American evangelism into a medical world view.

Originally antimedical, A.A. members often emphasized the failure of physicians to recognize alcoholism. Marty Mann, a publicist and early A.A. member, correctly saw this as a self limiting strategy. In 1944 she organized the National Committee for Education on Alcoholism (now the National Council on Alcoholism and Drug Dependence) as the public-relations arm of the movement, enlisting well-placed scientists and physicians to promote the disease model of alcoholism. Without this medical collaboration, A.A. could not have enjoyed the enduring success that distinguishes it from earlier temperance groups.

A.A. has now been incorporated into the cultural and economic mainstream. Indeed, many view A.A.'s 12-step philosophy as a cure not only for alcoholism but for a host of other problems. Twelve-step programs have been developed for drug addicts (Narcotics Anonymous), spouses of alcoholics (Al-Anon), children of alcoholics (Alateen), and people with literally hundreds of other problems (Gamblers Anonymous, Sexaholics Anonymous, Shopaholics Anonymous). Many of these groups and "diseases," in turn, are linked to counseling programs, some conducted in hospitals.


The medical establishment has come to recognize the financial and other advantages of piggybacking on the A.A. folk movement, as have many recovering alcoholics. A.A. members frequently make counseling careers out of their recoveries. They and the treatment centers then benefit from third-party reimbursement. In a recent survey of 15 treatment centers across the country, researcher Marie Bourbine-Twohig found that all of the centers (90 percent of which were residential) practiced the 12-step philosophy, and two-thirds of all counselors in the facilities were recovering alcoholics and addicts.

Early A.A. literature emphasized that members could succeed only if "motivated by a sincere desire." As their institutional base widened, A.A. and the disease approach became increasingly aggressive. This proselytizing tendency, originating in the religious roots of the movement, was legitimized by the association with medicine. If alcoholism is a disease, then it must be treated—like pneumonia. Unlike people with pneumonia, however, many people identified as alcoholics don't see themselves as sick and don't want to be treated. According to the treatment industry, a person with a drinking or drug problem who does not recognize its nature as a disease is practicing "denial."

In fact, denial of a drinking problem—or of the disease diagnosis and A.A. remedy—has come to be a defining characteristic of the disease. But indiscriminate use of the denial label obscures important distinctions among drinkers. While people sometimes do fail to recognize and acknowledge the severity of their problems, a drinking problem does not automatically prove a person is a lifelong alcoholic. Indeed most people "mature out" of excessive, irresponsible drinking.

The disease approach uses the concept of denial not only to force people into treatment, but to justify emotional abuse within treatment. Drug and alcohol programs typically rely on confrontational therapy (like that depicted in the film Clean and Sober) in which counselors and groups deride the inmates for their failings and their reluctance to accept the program's prescriptions. Most of the celebrities who graduate from such programs, out of either genuine belief or judicious discretion, report tough but positive experiences.

But the remarks of a critical minority are revealing. Actor Chevy Chase, for example, criticized the Betty Ford Center in Playboy and on TV talk shows after his 1986 stay there. "We called the therapy 'God squadding,'" he said. "They get you to believe that you're at death's door...that you've ruined it for everybody, that you're nothing and that you've got to start building yourself back up through your trust in the Lord...I didn't care for the scare tactics being used there. I didn't think they were right."

In a 1987 New York Times article, New York Mets pitcher Dwight Gooden described the group indoctrination at the Smithers Center in New York, where he was sent for cocaine abuse. Gooden, who had used cocaine at off-season parties, was browbeaten by fellow residents: "My stories weren't as good [as theirs]...They said, 'C'mon, man you're lying.' They didn't believe me...I cried a lot before I went to bed at night."

For every Dwight Gooden or Chevy Chase, there are thousands of less-famous people who have bitter experiences after being roped into treatment. Marie R., for example, is a stable married woman in her 50's. One evening she drove after drinking beyond the legal limit and was apprehended in a police spot check. Like most drunk drivers, Marie did not meet the criteria for alcoholism, which include routine loss of control. (Research by Kaye Fillmore and Dennis Kelso of the University of California has found that most people arrested for drunk driving are able to moderate their drinking.)

Marie admitted that she deserved to be penalized. Nonetheless, she was shocked when she learned that she faced a one-year license suspension. Although irresponsible, her carelessness was not as serious as the recklessness of a DWI whose driving clearly endangers others. Such disproportionate sentences push all but the most stubborn DWIs to accept "treatment" instead; indeed, this may be their purpose. Like most offenders, Marie thought treatment was preferable, even though she had to pay $500 for it.

Marie's treatment consisted of weekly counseling sessions, plus weekly A.A. meetings, for more than four months. Contrary to her initial expectations, she found the experience "the most physically and emotionally draining ordeal of my life." At A.A. meetings, Marie listened to ceaseless stories of suffering and degradation, stories replete with phrases like "descent into hell" and "I got down on my knees and prayed to a higher power." For Marie, A.A. was akin to a fundamentalist revival meeting.

In the counseling program provided by a private licensee to the state, Marie received the same A.A. indoctrination and met with counselors whose only qualification was membership in A.A. These true believers told all the DWIs that they had the permanent "disease" of alcoholism, the only cure for which was lifetime abstinence and A.A. membership—all this based on one drunk-driving arrest!

In keeping with the self-righteous, evangelistic spirit of the program, any objection to its requirements was treated as "denial." The program's dictates extended into Marie's private life: She was told to abstain from all alcohol during "treatment," a proscription enforced by the threat of urinalysis. As Marie found her entire life controlled by the program, she concluded that "the power these people attempt to wield is to compensate for the lack of power within themselves."

Money was a regular topic at the sessions, and counselors constantly reminded group members to keep up their payments. But the state picked up the tab for those who claimed they could not afford the $500 fee. Meanwhile, members of the group who had serious emotional problems searched vainly for competent professional counseling. One night, a woman said she felt suicidal. The group counselor instructed her, "Pray to a higher power." The woman dragged on through the meetings with no apparent improvement.

In lieu of real counseling, Marie and the others were forced to participate in a religious ritual. Marie became preoccupied by "the moral, ethical, and legal issue of coercing citizens into accepting dogma which they find offensive." Having had only a vague idea of the A.A. program, she was astounded to discover that "God" and a "higher power" are mentioned in half of A.A.'s 12 steps. For Marie, the third step said it all: "Made a decision to turn our will and our lives over to the care of God." Like many, Marie was not consoled that it was God "as we understood him."

She wrote in her diary: "I keep reminding myself that this is America. I find it unconscionable that the criminal justice system has the power to coerce American citizens to accept ideas that are anathema to them. It is as if I were a citizen of a totalitarian regime being punished for political dissent."


As Marie's story shows, court-mandated DWI referrals generate income for treatment entrepreneurs from insurance companies and state treasuries. The director of one treatment center says: "approximately 80 percent of my clients come via courts and deferred prosecution agreements. Many are simply taking advantage of the opportunity to avoid insurance premiums, blemished driving record, etc. and have no intention of changing their behavior."

Although DWIs constitute the largest number of referrals from the criminal-justice system, defendants are required to enter substance-abuse treatment for other crimes as well. In 1988, a quarter of Connecticut's probationers were under court order to enter alcohol or drug treatment. Penal systems are opting to treat the large number of drug offenders they face, both as an alternative to sentencing and as a condition of parole. The potential flow of treatment clients is huge: New York prison authorities estimate that three-quarters of all inmates in the state have abused drugs.

Adolescents are another rich source of treatment clients. (See "What's Up to Doc?," Reason, February 1991.) High schools and universities regularly direct students into A.A., sometimes based on isolated incidents of drunkenness. In fact, people in their teens and 20s represent the fastest-growing segment of the A.A. membership. The incarceration of adolescents in private mental institutions—primarily for substance abuse—grew by 450 percent during the 1980s. Teenagers almost always enter treatment involuntarily, whether under court order or under pressure (on them or their parents) from schools and other public agencies. In treatment they undergo "tough love" programs, which strip children of their pretreatment identities through techniques that often border on physical abuse.

In The Great Drug War, Arnold Trebach documents the shocking case of 19-year-old Fred Collins, who was pressured into residential treatment in 1982 at Straight Inc. near St. Petersburg, Florida by his parents and the organization's staff. Collins's and other inmates' parents collaborated with Straight in forcibly confining him for 135 days. Isolated from the out side world, he was subjected to 24-hour surveillance, sleep and food deprivation (he lost 25 pounds), and constant intimidation and harassment.

Collins eventually escaped through a window and, after months of hiding from his own parents, sought legal redress. In court, Straight did not contest Collins's account but instead claimed the treatment was justified because he was chemically dependent. Collins, an above-average student, presented psychiatric testimony that he had merely smoked marijuana and drunk beer occasionally. A jury found for Collins and awarded him $220,000, mostly in punitive damages. Nonetheless, Straight has never admitted its treatment program was flawed, and Nancy Reagan has continued to be a staunch advocate for the organization. Meanwhile ABC's "Primetime Live" and "20/20" have documented similar abuses in other private treatment programs.

Another major group of clients are those referred by employee-assistance programs (EAPs). While some employees seek counseling for a variety of problems, the main focus of EAPs has been substance abuse. Typically the initiative for treatment comes from the EAP rather than the employee, who must undergo treatment to keep his or her job. There are now more than 10,000 EAPs in the United States, most created in the last decade, and the number continues to grow. The majority of companies with at least 750 employees had EAPs by the mid-1980s.

EAPs often use "interventions," a technique that is popular throughout the treatment industry. An intervention involves surprising the targeted individual with a phalanx of family members, friends, and co-workers who, under the supervision of treatment personnel, browbeat the person into accepting that he or she is chemically dependent and requires treatment. Interventions are often spearheaded by counselors who are themselves recovering alcoholics. And usually the agency that assists with the intervention ends up treating the accused substance abuser.

"Interventions are the greatest advance in alcoholism treatment since Alcoholics Anonymous was founded," says the director of a California treatment center that depends on such clients. In a 1990 article in Special Report on Health entitled "Drunk Until Proven Sober," journalist John Davidson offered a different assessment: "The philosophical premise behind the technique appears to be that anyone—especially a recovering alcoholic—has the right to invade another's privacy, as long as he's trying to help."

Although employees who are subjected to such interventions are not coerced, they are usually threatened with dismissal, and their experiences often parallel those of criminal defendants who are forced to undergo treatment. Companies confronting employees suspected of drug or alcohol abuse make the same mistakes as courts do in handling drunk drivers. Most important, they fail to distinguish among different groups of employees suspected of substance abuse.

As the stories of Dwight Gooden and Helen Terry indicate, employees may be identified by an EAP even though their job performance is satisfactory. Random urinalysis may find drug traces, a record search may turn up an old drunk-driving arrest, or an enemy may submit a false report. Furthermore, not every employee who screws up at work is screwing up because of drugs or alcohol. Even when an employee's performance is suffering because of drug or alcohol use, this does not mean he or she is an addict or alcoholic. Finally, those employees who do have serious problems may not benefit from the 12-step approach.


For all its strong-arm tactics, mainstream drug and alcohol treatment does not seem to work very well. The few studies that have used random assignment and appropriate control groups suggest that A.A. works no better, and perhaps worse, than no treatment at all. The value of A.A., like that of any spiritual fellowship, is in the perceptions of those who choose to participate in it.

This year a study in The New England Journal of Medicine reported, for the first time, that employee substance abusers sent to private hospital programs had fewer subsequent drinking problems than employees who selected their own treatment (which generally meant either a hospital or A.A.). A third group sent to A.A. fared the worst of all.

Even in the hospital group, only 36 percent abstained throughout the two years following treatment (the figure was 16 percent for the A.A. group). Finally, although hospital treatment produced more abstinence, no differences in productivity, absenteeism, and other work-related measures were found among the groups. In other words, the employer who was footing the bill for treatment realized no greater benefit from the more expensive option.


Moreover, this study looked at private treatment centers, which cater to the sort of clients—well-to-do, educated, employed, with intact families—who most often straighten out on their own. The results for public treatment facilities are even less encouraging. A national study of public treatment facilities by the Research Triangle Institute in North Carolina found evidence of improvement for methadone maintenance and therapeutic communities for drug addicts, but no positive changes for people entering treatment for marijuana abuse or for alcoholism. A 1985 study published in The New England Journal of Medicine reported that just 7 percent of a group of patients treated in an inner-city alcoholism ward had survived and were in remission when followed up several years later.

All of these studies suffer from the flaw of not including a nontreatment comparison group. Such comparisons have most often been carried out with DWI populations. A series of such studies has shown that treatment of drunk drivers is less effective than judicial sanctions. For example, a major study in California compared four counties where drunk drivers were referred to alcohol rehabilitation programs with four similar counties where drivers licenses were suspended or revoked. After four years, DWIs in the counties imposing traditional legal sanctions had better driving records than those in the counties relying on treatment programs.

For nonalcoholic DWIs, programs teaching drivers the skills with which to avoid risky situations have proven superior to conventional A.A. education programs. Indeed, research has shown that, even for highly alcoholic drinkers, teaching life management skills, rather than lecturing about the disease of addiction, is the most productive form of treatment. The training covers communication (particularly with family members), job skills, and the ability to "cool out" under stressful conditions that often lead to excessive drinking.

Such training is the standard for treatment in most of the world. Given the spotty record of the disease-model treatment, one would think that U.S. programs would be interested in exploring alternative therapies. Instead, these remain anathema to treatment facilities, which see no possibilities beyond the disease model. Last year, the Institute of Medicine of the prestigious National Academy of Sciences issued a report calling for a much wider range of treatments to respond to the variety of individual preferences and drinking problems.


By accepting the notion that people who have drinking or drug problems (or are merely identified by others as having problems) suffer from a disease that forever negates their personal judgment, we have undermined the right of people to change their behavior on their own, to reject labels they find inaccurate and demeaning, and to choose a form of treatment they can be comfortable with and believe will work for them. At the same time, we have given government support to group indoctrination, coerced confessions, and massive invasions of privacy.

Fortunately, the courts have supported those seeking protection from coercive treatment. In every court challenge to mandated A.A. attendance to date—in Wisconsin, Colorado, Alaska, and Maryland—the courts have ruled that A.A. is equivalent to a religion for First Amendment purposes. The state's power is limited to regulating people's behavior, not controlling their thoughts.

In the words of Ellen Luff, the ACLU attorney who successfully argued the Maryland case before a state appeals court, the state may not "intrude further into the probationer's mind by forcing sustained attendance in programs designed to alter their belief in God or their self identity." Whether or not any established religion is involved, she concludes, "if the state becomes. a party to attempting to precipitate a conversion experience, the First Amendment has been violated."

Decisions like the one in Maryland, issued in 1989, have not deterred the director of the court-sanctioned Right Turn program in Massachusetts, who declares. "The basic principle about entering A.A. voluntarily is debatable, because most non-Right Turn members of A.A. were forced into the program by other pressures; for instance a spouse or an employer delivered a last ultimatum." Leaving aside the assumption that the typical drunk driver resembles the alcoholic who voluntarily goes to A.A., the equation of judicial coercion with social or economic pressure would leave us with no Bill of Rights.

In place of today's confused, corrupt tangle of treatment, law enforcement, and personnel management, we propose the following guidelines:

Punish misbehavior straightforwardly. Society should hold people accountable for their conduct and penalize irresponsible destructive behavior appropriately. For example, drunk drivers should be sentenced, irrespective of any presumed "disease state," in a manner commensurate with the severity of their reckless driving. At the lower end of DWI offenses (borderline intoxication), the penalties are probably too severe; at the upper end (repeat offenders, reckless drunk driving that endangers others, vehicular homicide), they are too lenient. Penalties should be uniform and realistic—for example, a one-month license suspension for a first-time drunk driver who did not otherwise drive recklessly—since they will actually be carried out.

Similarly, employers should insist that workers do their jobs properly. When performance is not satisfactory, for whatever reason, it may make sense to warn, suspend, demote, or fire the employee, depending upon how far short of accepted standards he or she falls. Treatment is a separate issue; in many cases—for example, when the only indication of substance abuse is a Monday-morning hangover—it's inappropriate.

Offer treatment to those who seek help, but not as an alternative to accountability. Coercive treatment has such poor results in part because offenders typically accept treatment as a way to avoid punishment. Courts and employers should provide treatment referrals for those who want help in extricating themselves from destructive habits, but not as a way to avoid penalties.

Offer a range of therapeutic alternatives. Treatment should reflect individual needs and values. For treatment to have its greatest impact, people must believe in it and take responsibility for its success because they have chosen it. Americans should have access to the range of treatments used in other countries and proven effective in clinical research.

Emphasize specific behaviors, not global identities. "Denial" is often a response to the mindless insistence that people admit they are addicts or alcoholics. This resistance can be circumvented by focusing on the specific behavior that the state has a legitimate interest in modifying—for instance, driving while intoxicated. A practical, goal-oriented approach, implemented through situational and skills training, has the best chance of changing behavior.

There is no better motivation for change than the experience of real-world punishments for misbehavior. By comparison, coercive treatment on a religious model is notably ineffective. And it is one of the most blatant and pervasive violations of constitutional rights in the United States today. After all, even murderers on death row are not forced to pray.

next: Alcohol and Society
~ all Stanton Peele articles
~ addictions library articles
~ all addictions articles

APA Reference
Staff, H. (2009, January 2). AA Abuse, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/addictions/articles/aa-abuse

Last Updated: June 27, 2016

Warning Signs of Violence in Children

Maybe you're not sure if your child is violent. Here are signs that your preschool or school-aged child or teenager may be violent.

Warning Signs in the Toddler and Preschool Child:

  • Has many temper tantrums in a single day or several lasting more than 15 minutes, and often cannot be calmed by parents, family members, or other caregivers;
  • Has many aggressive outbursts, often for no reason;
  • Is extremely active, impulsive, and fearless;
  • Consistently refuses to follow directions and listen to adults;
  • Does not seem attached to parents; for example, does not touch, look for, or return to parents in strange places;
  • Frequently watches violence on television, engages in play that has violent themes, or is cruel toward other children.

Warning Signs in the School-Aged Child:

  • Has trouble paying attention and concentrating;
  • Often disrupts classroom activities;
  • Does poorly in school;
  • Frequently gets into fights with other children in school;
  • Reacts to disappointments, criticism, or teasing with extreme and intense anger, blame, or revenge;
  • Watches many violent television shows and movies or plays a lot of violent video games;
  • Has few friends, and is often rejected by other children because of his or her behavior;
  • Makes friends with other children known to be unruly or aggressive;
  • Consistently does not listen to adults;
  • Is not sensitive to the feelings of others;
  • Is cruel or violent toward pets or other animals;
  • Is easily frustrated.

Warning Signs in the Preteen or Teenage Adolescent:

  • Consistently does not listen to authority figures;
  • Pays no attention to the feelings or rights of others;
  • Mistreats people and seems to rely on physical violence or threats of violence to solve problems;
  • Often expresses the feeling that life has treated him or her unfairly;
  • Does poorly in school and often skips class;
  • Misses school frequently for no identifiable reason;
  • Gets suspended from or drops out of school;
  • Joins a gang, gets involved in fighting, stealing, or destroying property;
  • Drinks alcohol and/or uses inhalants or drugs.

This material was excerpted from is a brochure produced through a collaborative project of the American Psychological Association and the American Academy of Pediatrics. Full text copies of the brochure are available by contacting the American Academy, Division of Publications, 141 Northwest Point Blvd, PO Box 927, Elk Grove Village, IL. 60009-0927. Copyright © 1996 American Psychological Association. All Rights Reserved.

If you are seeking immediate guidance or help about your son or daughter, our Virtual Clinic provides email, chat room, and telephone therapy for assistance in your situation.

If you are a mental health professional, please refer to our Seminars to arrange a comprehensive training workshop on the impact of the media violence on families.



next:   Do You Spend Too Much Time Online?
~ all center for online addiction articles
~ all articles on addictions

APA Reference
Staff, H. (2009, January 2). Warning Signs of Violence in Children, HealthyPlace. Retrieved on 2024, September 28 from https://www.healthyplace.com/addictions/center-for-internet-addiction-recovery/warning-signs-of-violence-in-children

Last Updated: October 6, 2015